Identifikation und Charakterisierung von synaptischen Proteinen von Drosophila melanogaster mit Hilfe von monoklonalen Antikörpern der Würzburger Hybridoma-Bibliothek by Halder, Partho
 
 
Identification and characterization of synaptic proteins of Drosophila melanogaster using 
monoclonal antibodies of the Wuerzburg Hybridoma Library. 
 
Identifikation und Charakterisierung von synaptischen Proteinen von Drosophila 
melanogaster mit Hilfe von monoklonalen Antikörpern der Würzburger Hybridoma-
Bibliothek 
 
Doctoral thesis for a doctoral degree 
at the Graduate School of Life Sciences, 
Julius-Maximilians-Universität Würzburg, 
Section Neuroscience. 
 
 
submitted by 
Partho Halder 
 
 
from 
Ranchi, India 
 
 
Wuerzburg, 17 August  
2011 
	   3	  
 
 
 
 
 
 
 
 
 
 
 
Submitted on:     ……………………………. 
 
 
 
 
Members of the Promotionskomitee: 
 
Chairperson:     Prof. Dr. Michael Sendtner 
 
Primary Supervisor:    Prof. Dr. Erich Buchner 
 
Supervisor (Second):    PD Dr. Alois Hofbauer 
 
Supervisor (Third):   Prof. Dr. Stephan Sigrist 
 
 
 
Date of Public Defence:   ……………………………. 
 
Date of Receipt of Certificates: ……………………………. 
 
 
	   4	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dedicated to my family. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   5	  
INDEX 
 
Abbreviations          1 
 
1. Introduction 
1.1 Nervous system to neurons to synapses to synaptic proteins 3 
1.2 Drosophila as a model organism             11 
1.3 Monoclonal Antibody of the IgM class            13 
 
2. Materials 
2.1  Fly strains                 18 
2.2  Buffers and reagents 
   2.2.1     SDS-PAGE        
   2.2.1.1 Mini Protean™ (BioRad®) system            18 
   2.2.1.2 Novex Mini XCell™ (Invitrogen®) system           19 
      2.2.1.3  Tricine SDS-PAGE              19 
 2.2.2  Western Blotting               20 
 2.2.3   Coomassie Staining               
    2.2.3.1  CBB R250                21 
    2.2.3.2  Colloidal CBB G250              21 
 2.2.4   Silver Staining               21 
 2.2.5  Destaining of silver stained gels            22 
 2.2.6   Immunoprecipitation              22  
 2.2.7  Protein precipitation               
    2.2.7.1 TCA precipitation               23 
    2.2.7.2 Chloroform Methanol precipitation            23 
    2.2.7.3 Ethanol precipitation              23 
 2.2.8   Hybridoma cell culture              23 
 2.2.9   Capture ELISA for Isotyping             23 
 2.2.10  Subcellular fractionation              24 
 2.2.11  Two dimensional electrophoresis (IEF/SDS)           24 
 2.2.12  Two dimensional electrophoresis (NEPHGE/SDS)          24 
 2.2.13  Grape juice agar for egg laying             25 
 2.2.14  Cryosectioning and Immunostaining            26 
 2.2.15  Adult brain whole mounts             26 
 2.2.16  Larval brain whole mounts             27 
 2.2.17  Larval NMJ dissection              27 
 2.2.18  Proteoliposome formation             27 
 2.2.19 Hydroxyapatite column chromatography           27 
 2.2.20 Ion exchange chromatography             28 
2.3 Protein marker                28 
	   6	  
2.4 Antibodies                 28 
 
3. Methods  
3.1 Fly rearing                 30 
3.2 Collection of large amount of fly heads            30 
3.3 Hybridoma cell culture and mAb production            30 
3.4 Production of serum free supernatant             31 
3.5 Cryopreservation of cell lines              32 
3.6 Characterization of the mAbs              32 
3.7 Protein quantification               32 
3.8 Protein precipitation 
   3.8.1 TCA precipitation               32 
   3.8.2 Chloroform Methanol precipitation            33 
   3.8.3  Ethanol precipitation              33 
3.9 Sub-cellular fractionation of fly head                     33 
3.10 Subfractionation of total membrane fraction            34 
3.11 Generation of proteoliposomes 
   3.11.1  By simple dilution below CMC             34 
   3.11.2 By gel filtration chromatography            35 
3.12 Immunoprecipitation for enrichment of na21 antigen          35 
3.13 Resolution of proteins by electrophoresis 
   3.13.1  One dimensional SDS-PAGE with self made gels          36 
   3.13.2  One dimensional SDS-PAGE with pre-cast gels          36 
   3.13.3  Tricine SDS-PAGE              36 
   3.13.4  Two dimensional electrophoresis (IEF/SDS)           37 
   3.13.5  Two dimensional electrophoresis (NEPHGE/SDS)          38 
3.14 Western blotting                39 
3.15 Partial Western blotting               40 
3.16 Staining of proteins in gels 
   3.16.1  Coomassie R250 staining             40  
   3.16.2  Coomassie G250 staining             41 
   3.16.3  MS compatible silver staining             41 
   3.16.4   Destaining silver stained gels             42 
3.17 Cryosections and immunostaining             42  
3.18  Collection of eggs                43 
   3.18.1  Selection of EPS-15 homozygous mutants           44 
3.19  Adult brain whole mounts              44 
3.20 Larval brain whole mounts              46 
3.21 Purification of IgM by CHA column chromatography          47 
3.22  Partial enrichment of the na21 antigen by ion exchange           47 
	   7	  
  chromatography 
 
4.  Results and Discussion 
4.1 Monoclonal antibody ab52              49 
   4.1.1 Discussion                58  
4.2 Monoclonal antibody na21              61 
   4.2.1 Discussion                78 
4.3 Other mAbs                 82 
   4.4  Discussion                88 
 
5.   Summary                  90  
 
6.   Zusamenfassung                  92 
 
7.   References                  94 
 
8.   Appendix 
   8.1  Publcations                       105 
8.2  Curriculum Vitae               107  
8.3 Hits from mass spectrometric analysis of 2DE spot         112  
 
 
 
 
 
 
 
 
 
 
 
 
	   8	  
ACKNOWLEDGEMENT 
“Knowledge is in the end based on acknowledgement.”      -Ludwig Wittgenstein  
First of all I am highly grateful to Prof. Dr. Erich Buchner for accepting me as a 
doctoral student under his kind supervision. I am thankful to him for his 
mentorship and support throughout my thesis and for the different ways in which 
he has inspired me and the various things that I have got to learn from him. 
I am also thankful to my co-supervisors: PD Dr. Alois Hofbauer and Prof. Dr. 
Stephan Sigrist for all their suggestions, feedback and guidance throughout my 
thesis. I am also grateful to the heads of the department Prof. Dr. Martin 
Heisenberg (earlier) and Prof. Dr. Charlotte Förster (later) for providing a 
congenial and stimulating working environment. I am highly grateful to the 
Graduate School of Life Science, for selecting me as one of the first batch of 
fellows and giving me this opportunity to do my doctoral thesis at the University of 
Wuerzburg. I am thankful to the entire staff of the GSLS for their help and support. 
I am also thankful to DAAD STIBET for the fellowship near the end of my thesis 
and to Prof. Dr. Michael Sendtner at the Institute for Clinical Neuroscience for 
supporting me for the last two months of my thesis. 
I would like to thank all my colleagues: Alex, Alice, Andrea (Kaiser), Andrea 
(Schneider), Bea, Dominique, Janine, Mandy and members of the Sendtner lab. I 
am also grateful to Frau Mohr and Frau Stahl for the administrative support at the 
department. I am also thankful to Prof. Dr. Hildeburge Beier, Prof. Dr. Marie-
Christine Dabauvalle, Dr. Clemens Grimm, Prof. Dr. Reinhard Jahn and Prof. Dr. 
Albert Sickmann for their collaborations. Special thanks to Barbara, Dieter, 
Gertrud and Ursel for their excellent technical assistance. 
My special thanks go to my friends (in alphabetical order) Amulya, Andreas, 
Jayavarshini, Preeti, Shambhavi, and others for always being there for me through 
the ups and downs of my life during the last four years. 
Finally I would like to thank my parents and my sister for all their patience, 
encouragement and support in helping me to do whatever I have been able to. It 
would never have been possible without the foundations they laid and all the 
sacrifices they made, especially in tolerating the huge separation between us. I 
would thus like to dedicate this work to them. I apologize if I miss someone and I 
want to thank all those who taught me something in my journey in the last four 
years.
	  	   9	  
ABBREVIATIONS 
AIDS  Acquired Immune Deficiency Syndrome        
APS   Ammonium PeroxydiSulfate          
BCA  BiCinchoninicAcid or 2-(4-carboxyquinolin-2-yl)quinoline-4-
carboxylic acid              
BSA   Bovine Serum Albumin           
Ca+2  Calcium divalent cation          
CBB   Coomassie Brilliant Blue          
CHT  Ceramic Hydroxyapatite           
CMC  CarboxyMethylCellulose          
CMC  Critical Micelle Concentration           
CNS   Central Nervous System             
CS  Canton S             
CSP  Cysteine String Protein           
Cy3  Cyanine3              
CyO  Curly of Oster                 
D   Diffusion coefficient        
DMA  N,N-Dimethylacrylamide               
DMSO DiMethyl SulfOxide                   
DTT   Dithiothreitol or (2S,3S)-1,4-Bis-sulfanylbutane-2,3-diol           
ECL™  Enhanced ChemiLuminescence               
EDTA  2,2',2'',2'''-(Ethane-1,2-Diyldinitrilo)Tetraacetic Acid            
EGTA Ethylene Glycol-bis(2-aminoethylether)-N,N,N′,N′-Tetraacetic Acid 
ELISA  Enzyme-Linked ImmunoSorbent Assay                
EPS-15 Epidermal growth factor receptor Pathway Substrate clone 15        
FBS   Fetal Bovine Serum              
Fc  Fragment crystallisable                 
GAL4 Galactose 4 (yeast transcription activator of galactose-induced genes) 
GFP  Green Fluorescent Protein           
HA   HydroxyApatite            
HCS   Hybridoma Cloning Supplement          
HEP   Hybridoma Express Plus               
HEPES 2-[4-(2-HydroxyEthyl)Piperazin-1-yl]EthaneSulfonic acid      
HRP   Horse Radish Peroxidase                
HSP70 Heat Shock Proteins of 70 kDa            
HT   Hypoxanthine-Thymidine          
IAA  2-Iodoacetamide             
IEF   IsoElectricFocusing            
IgG  Gammaimmunoglobulin           
	  	   10	  
IgM   Macroimmunoglobulin          
MGUS  Monoclonal Gammopathy of Undetermined Significance         
IP   ImmunoPrecipitation           
IPG   Immobilized pH Gradient               
κ  kappa chain             
mAb   monoclonal Antibody            
MS  Mass Spectrometry               
MUNC Mammalian UNCoordinated protein         
NEPHGE  Non-Equilibrium pH Gradient gel Electrophoresis            
NFDM Non Fat Dry Milk             
NMJ   Neuro-Muscular Junction          
NP-40 Nonidet P-40 (Octylphenoxypolyethoxyethanol)      
NSF  N-ethylmaleimide Sensitive Fusion protein       
PAA  PolyAcrylAmide               
PC   Phosphatidylcholine           
PDB   Protein Data Bank              
PE  Phosphatidylethanolamine         
PFA   Paraformaldehyde (Polyoxymethylene)          
pH  Power of Hydrogen                  
PIPES 1,4-PIPerazinediREthaneSulfonic acid        
Rab  Ras-related in brain protein       
Rhod-PE  1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine  
rhodamine B sulfonyl) (ammonium salt)                  
RER   Rough Endoplasmic Reticulum       
RPMI 1640 Roswell Park Memorial Institute 1640 medium         
RT   Room Temperature                
S  Svedberg unit                   
SDS-PAGE Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis  
SNAP SyNaptosomal-Associated Protein            
SNARE Soluble NSF Attachment protein Receptor     
SRPK  Serine/Arginine Protein Kinase       
TBCE  Tubulin Binding Chaperone E         
TCA  TriChloroacetic Acid             
TEMED  N,N,N',N'- TEtraMethylEthyleneDiamine             
Tween 20 Polyoxyethylene (20) sorbitan monolaurate          
twi  twist (mesoderm specific promoter)        
UAS   Upstream Activation Sequence               
VAMP Vesicle Associated Membrane Protein  
 
	  	   11	  
Chapter 1   INTRODUCTION 
 
1.1 Nervous system to neurons to synapses to synaptic proteins 
All living organisms have a fundamental property, i.e. the ability to extract, 
transform and use energy from the environment which enables them to carry out 
the various life processes like nutrition, locomotion, reproduction, etc which are 
performed by specialized organ systems. One such organ system is the nervous 
system, which has the ability to receive stimuli through sensory organs, process 
them and evoke required responses. The ability to sense stimuli and react to them 
was already present in single celled organisms (eg. movement towards the 
increasing gradient of nutrient concentration by chemotaxis in prokaryotes), but 
with increase in number of cells in metazoans there was need for the evolution of a 
more sophisticated organ system that could connect and co-ordinate the various 
cells as a single responsive system. Besides the various incoming sensory stimuli 
also needed a processing system to elicit the necessary responses that would enable 
the organism to respond to a given stimulus in the right way to ensure its survival. 
Further with increase in complexity in the nature of the incoming signals and the 
amount of processing required the need for a highly specialized organ system 
arose. This need was fulfilled by the evolution of the nervous system, which had 
specialized cells which could capture incoming stimulus, transmit these signals to 
the processing center and finally transmit the generated response to the effector 
cells. So this system had the unique ability of transmitting the signals between the 
cells within the body of the organism also over long distances, in the form of 
electrical and chemical signals. With its ability to process the input data into 
meaningful information and generate a suitable response as output, the nervous 
system was ‘nature’s computer’ with a processor and wires that connected it to all 
the input and output devices. 
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The simplest nervous system evolved in organisms of the phylum Cnidaria (eg. 
Hydra) as diffuse network of nervous cells which had long processes to physically 
connect to other cells over long distances and acted more or less in coordination. In 
higher animals the specialized nervous cells began to bundle their long processes 
into fibers and this further evolved into ‘nerves’, which could transmit the 
electrochemical messages more efficiently over large distances, analogous to wires 
carrying electrical signals. The electro-chemical nature of the signals also allowed 
faster transmission and hence better responsiveness to the system and the 
organism. Evolution of bilateral symmetry in life forms, led to organization of this 
system by clustering of sensory nerve cells with photo-, gustatory and olfactory 
receptors towards the anterior part of the body. This process of ‘cephalization’ of 
the most of the sensory organs gave evolution of the body part called ‘head’ which 
contained the clustered neurons within as the ‘brain’ and the bundled nerves 
extended to the posterior side as the ‘longitudinal nerve cord’. The brain and the 
longitudinal nerve cord together comprised the ‘central nervous system’ (CNS) and 
is analogous to the computer’s processing unit. The simplest CNS is found in the 
phylum Platyhelminthes (flat worms eg. Planarians). In more complex 
invertebrates such as Annelida the nervous system has the brain and the ventral 
nerve cord containing segmentally arranged cluster of neurons called ganglia. Both 
annelids and arthropods have a ganglion in each body segment (segmental 
ganglia). Other species in the animal kingdom, such as slow molluscs (eg. Chitons) 
have little or no cephalization, while cephalopod mollusks like squids have the 
most sophisticated nervous system among all invertebrates. Gradually in 
vertebrates the nervous system evolved more to gain the highest level of 
complexity in form of the human brain. Such complex nervous systems, have 
specific neural circuits dedicated to carry specific information to specialized 
centers in the nervous system which are responsible for processing of the 
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information. So the nervous system of higher organisms is a large aggregate of 
numerous processing centers which are connected to each other in a complex 
network, much more complex than the most complicated network of the circuit 
elements of even the most advanced microporcessor. The enigma of such 
complexity of the neuronal networks however could not discourage scientists from 
studying the organization of these networks. One of the first milestones in the 
elucidation of this network was the ‘reticular theory’ proposed to explain the 
morphology and functioning of the nervous system (Golgi, 1906), and was later 
replaced by the ‘neuron doctrine’ (Ramón y Cajal, 1906).  
The unique electrical and physiological functions of the nervous system are due to 
the special structural and biochemical properties of the cells that constitute it. Cells 
of the nervous system are broadly classified into two major types: 
a) Neurons     b) Glia.  
Neurons (coined by Ramón y Cajal) are electrically excitable cells, which can 
generate of a plasmalemmal ‘all-or-none’ action potential, capable of propagating 
through surface of the cell membrane as an ionic current due to sequential opening 
and closing of specific ion channels. The signal is further transmitted between two 
cells as a chemical or electrical signals. Hence neurons transmit the signals over 
long distances through a given network. They possess special electrical and 
chemical properties to carry out these functions. Glia on the other hand are 
nonexcitable cells of the nervous system. Various types of glia play diverse roles in 
genesis, development, nutrition, control, damage repair etc of adjacent neurons and 
their circuits. According to current estimates the adult human brain possesses 
around 100 billion neurons and around 9-fold more glial cells (Verkhratsky and 
Butt, 2007). 
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A typical neuron consists of a cell body (soma/ perikaryon) and long cellular 
processes called neurites which are of two major types namely dendrites and 
axons. Besides other common organelles the soma contains Nissl bodies, which are 
aggregates of rough endoplasmic reticulum (RER) and free ribosomes acting as 
sites of active protein synthesis. Dendrites are highly branched extensions of the 
soma that increase the surface area and can account for up to 90% of the 
cytoplasmic membrane area of a typical neuron (Martini and Bartholomew, 2010). 
Distinctive features of neurons are their axons, usually a single, long cylindrical 
process that carries the information received at the soma to other cells as electrical 
impulses. It lacks most organelles, but is rich in cytoskeletal elements and transport 
vesicles for delivering any required cellular machinery to the distal end of the 
neuron. It also contains mitochondria to deliver the energy for all its local 
activities. 
 
Besides their special electrical and chemical properties, neurons also have 
specialized morphological features to carry out the functions of information 
transmission. The transmission of information between cells of a neural circuit 
occurs via points of contacts between cells. The specialized contacts where the 
signals are transmitted from one neuron to the other were named ‘synapses’ (from 
the Greek word synaptein, meaning to bind together) by Sir Charles Scott 
Sherrington (Sherrington, 1906). The majority of synaptic inputs from other 
neurons are usually received at the dendrites. 
A typical chemical synapse has two parts: the presynaptic side (Murthy and De 
Camilli, 2003) comprising enlarged structures at the distal part of the axon called 
presynaptic terminals (by Ramón y Cajal) which abut the postsynaptic side 
comprising postsynaptic densities and receptors, etc (Sanes and Lichtman, 2001). 
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The two sides are separated by a narrow gap of 10-200 nm, called the synaptic 
cleft. Signal transmission across the synaptic cleft in the majority of synapses 
occurs chemically. In these chemical synapses, specific messenger molecules 
called neurotransmitters are contained in membranous sacs, which were discovered 
by electron microscopy and were called ‘synaptic vesicles’ (SVs) by Bernard Katz. 
The neurotransmitters are released by exocytosis (Fernandez-Chacon and Südhof, 
1999) at specialized presynaptic sites, called active zones (Schoch and 
Gundelfinger, 2006) in response to Ca+2 influx caused by the incoming electrical 
signal. (Lin and Scheller, 2000; Pang and Südhof, 2010). However, chemical 
synapses are ‘reliably unreliable’ and every action potential is not converted into a 
secretory signal. Infact in most terminals, only 10%–20% of action potentials 
trigger an actual release (Goda and Südhof, 1997). The neurotransmitter molecules 
released by the fused SVs then diffuse across the synaptic cleft and bind to their 
corresponding receptors on the postsynaptic side, leading to an electrical or 
chemical signal in the postsynaptic cell. Thus the information travels down a 
neural network as a train of electro-chemical signals. In an electrical synapse 
(Meier and Dermietzel, 2006), on the other hand, the signal is transmitted only as 
current (ionic fluxe) through special ion pores called connexons, which form form 
a specialized form of tight-junction called gap junction. Electrical synapses 
constitute only a small proportion of all synapses in an adult brain. Other types of 
tight-junctions are more abundant in epithelial and muscular tissues (Meşe et al., 
2007). Fusion of SVs in response to a membrane depolarization is called active 
release. The random fusion of single SVs in absence of any electrical stimulus is 
called spontaneous release (Fatt and Katz, 1952) and generates small postsynaptic 
currents called miniature postsynaptic current. Inspired by Max Planck’s ‘Quantum 
Theory’, Katz described the event of fusion of an individual SV as discrete quanta 
of neurotransmission which is popularly referred to as the ‘quantal release theory’ 
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(Del Castillo and Katz, 1954). It was later replaced by the ‘vesicle release theory’ 
(Del Castillo and Katz, 1955). Today is it estimated that, an average 42 nm sized 
SV contains ~1500 neurotransmitter molecules that can be released simultaneously 
(Haucke et al., 2011). Infact the SV is often considered the most well characterized 
organelle of the cell (Takamori et al., 2006). 
Each neuron with its highly branched structure, has the possibility to form 
numerous synpases with many adjacent cells. The synaptic connections of a typical 
circuit comprise a dense tangle of dendrites, axons terminals and glial (cellular) 
processes that are together called ‘neuropils’. With a high cell density, numerous 
possibilities to intercommunicate and the inherent property of nervous system to 
comprise of complex neural circuits, the human brain is probably the ‘most 
complex network system’ in the known universe. Modern neuroscience aims to 
understand the functioning of this complex system. It was probably the increasing 
synaptic connectivity and the consequent increase in complexity of the brain that 
led to the evolution of higher brain functions like consciousness, perception, 
attention, cognition, thought, emotions, behavior, learning and memory etc. The 
molecular basis of these higher brain functions is still far from being well 
understood and a substantial part of the modern neuroscientific community 
continues to pursue this aspect. Learning and memory are among such higher brain 
functions, which have been widely studied at our department for quite some time. 
Learning can be simply be defined as the modification of existing (or acquisition of 
new) knowledge, behaviours, skills, etc., while memory can simply be defined as 
the ability to store, retain, and recall information and experiences. Memory is 
thought to arise as a ‘memory trace’ and then stored as an ‘engram’. An engram is 
a hypothetical means by which memory traces are stored as biophysical or 
biochemical changes in the brain (and other neural tissue) in response to external 
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stimuli. One such theory of memory formation is the synaptic tagging and capture 
hypothesis (Redondo and Morris, 2011). The synapse has the ability to change its 
strength (level of activity) in response to stimuli by either use or disuse. Such 
activity-dependent modification of synaptic strength is called synaptic plasticity 
and is thought to be one of the possible mechanisms of formation of the traces 
leading to memory formation (Martin and Morris, 2002). Synaptic plasticity is thus 
considered one of the important neurochemical foundations of learning and 
memory (Kandel, 2000). Synaptic plasticity comprises both: 
i) morphological changes in synapses, i.e. changes in number of synapses 
(formation of new synapses to strengthen an existing circuit or loss of existing 
synapses for abating/removing a circuit) and, 
ii) functional changes in synapses i.e. increasing the rate of activity of a 
synapse or decreasing its rate of activity for a given amount of stimulus. 
These structural and functional changes in synapses ultimately influence the 
fundamental process of synaptic neurotransmission. Hence the understanding of 
synaptic neurotransmission is required for the understanding of synaptic plasticity. 
Fusion of synaptic vesicles at the active zone is followed by retraction of the fused 
vesicle by endocytosis, such that it can be refilled with neurotransmitters and 
reused for neurotransmission (Heuser and Reese, 1973). This recycling of SVs has 
evolved for enable synapses to quickly prepare themselves for continued 
neurotransmission. This is of particular important for highly active synapses which 
need to maintain a high rate of transmission (Shupliakov and Brodin, 2010). The 
whole process of from SV fusion to its endocytic re-uptake and reuse is called the 
‘synaptic vesicle cycle’ illustrated in the Fig. 1 below. Each of the steps including 
docking, priming, fusion and recycling are a highly co-ordinated process executed 
by the complex interplay of several proteins acting at the SV surface and active 
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zone (Jahn et al., 2003; Sudhof, 2004). Fusion itself is highly interesting process 
involving a wide repertoire of highly conserved proteins as shown in Fig. 2, 
notable among which are: SNAREs (Jahn and Scheller, 2006), and SM proteins 
(Carr and Rizo, 2010). The neuronal synapse is thus a highly active site of each 
neural unit and its proper functioning is indispensible for normal neural activity. 
The synapse contains many proteins which contribute to its structural and 
functional aspect. Significant among them are Piccolo, Bassoon, Rabs, Synapsins, 
CSPs, SNAPs, Syntaxins, VAMPs, etc some of which are shown below in Fig. 2. 
These proteins often exist as multiple isoforms each of which has its own functions 
(Richmond, 2007). 
 
Fig. 1. Synaptic vesicle cycle (modified from Haucke et al., 2011). 
Our group works on synaptic proteins in Drosophila melanogaster. The aim is to 
identify novel proteins in the synapses of Drosophila melanogaster and to 
understand their role in the structural organization and functioning of the synapse. 
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Synaptic proteins studied in our lab include Synapsins (Klagges et al., 1996), 
Bruchpilot (Wagh et al., 2006; Kittel et al., 2006), SAP-47 (Reichmuth et al., 
1995), CSP (Zinsmaier et al., 1990), SRPK 79D (Nieratschker et al., 2009), TBCE-
like etc. The identification of many such novel synaptic proteins was facilitated by 
the monoclonal antibodies of the Wuerzburg Hybridoma Library (Hofbauer 1991; 
Hofbauer et al., 2009). Besides synaptic vesicles that different kinds vesicles 
(endosomes, secertory vesicles, etc.) also occur in all types of cells, further makes 
the study of synaptic neurotransmission significant in elucidating the fundamental 
mechanism of membrane fusion (Söllner, 2004). Drosophila has been chosen as the 
experimental model organism for these studies because of its advantages. 
 
Fig. 2. Schematic of a typical synapse with the major synaptic proteins. 
(Adapted from http://www.sysy.com/flash-synapse/index2.html) 
 
1.2 Drosophila as a model organism: Drosophila melanogaster is commonly 
known as the fruit fly and is a dipteran insect as illustrated below.  
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Kingdom :  Animalia   Phylum :  Arthropoda 
Class  :  Insecta   Order  :  Diptera 
Family :  Drosophilidae  Subfamily :  Drosophilinae 
Genus :  Drosophila   Subgenus :  Sophophora 
Species :  D. melanogaster 
 
Charles W Woodworth began breeding fruit flies and proposed their use as model 
organism for genetic studies to William E Castle who further passed it on to Frank 
E Lutz who then introduced them to Thomas Hunt Morgan (Morgan, 1934). 
Features like short generation time, high reproductive rate, reasonable costs, ease 
of handling, etc made it an instant favorite. While the ethical constraints of 
vertebrate model organisms were not involved, most of the vertebrate genes were 
present due to high degree of evolutionary conservation making the fruit fly a 
valuable experimental model. Consequently it became the model which led to 
many seminal discoveries were made by Morgan’s group in the ‘Fly Room’ of the 
Columbia University which enlightened almost all aspects of biology. The gradual 
development of various genetic tools (Ryder and Russell, 2003) for genetic 
manipulations like transgenic expression, miss-expression, mutagenesis, etc., 
facilitated Drosophila as one of the most powerful tools for genetic research. The 
possibility of spatio-temporal control of gene-expression using binary expression 
systems like the UAS-GAL4 (Elliott and Brand, 2008) further enhanced the 
possibilities in genetic research using Drosophila. Today more than a century after 
its introduction, D. melanogaster is one of the best established model organisms 
used in almost all facets of biological research (Arias, 2008) including 
neuroscience (Bellen et al., 2010). Inspite of being an invertebrate it is a suitable 
model to study vertebrate diseases (Botas, 2007; Doronkin and Reiter, 2008) 
including neurodegeneration (Lu and Vogel, 2009; Ambegaokar et al., 2010).  
My doctoral project also aimed to identify and characterize synaptic proteins in the 
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fruitfly, Drosophila melanogaster with the help of monoclonal antibodies from the 
Wuerzburg Hybridoma Library. 
 
1.3 Monoclonal Antibody of the IgM class: The Wuerzburg Hybridoma Library 
is a valuable resource as it contains more than 200 monoclonal antibodies. 
Monoclonal antibodies (mAbs) are one of the most important tools in modern 
biology and have come a long way from being mere analytical tools to becoming 
indispensible in diagnostics as well as therapeutics (Albrecht et al., 2009). They are 
used in treatment for a wide variety of diseases like cancers (Weiner et al., 2010), 
immunological disorders (Chan and Carter, 2010), respiratory diseases (Schachter 
and Neuman, 2009), infectious diseases (Lachmann, 2009). Today, mAbs represent 
over 30% of all biological proteins undergoing clinical trials and are the second 
largest class of biodrugs after vaccines (Elbakri et al., 2010) and with the advent of 
more efficient, genetically engineered antibodies (Cuesta et al., 2010; Li and Zhu, 
2010) this trend is expected to grow (Aires da Silva et al., 2008; Nelson et al., 
2010). Non-allowance of ascites in many countries and cumbersomeness of other 
methods makes hybridoma cell culture as the most popular methods even today.  
 
Antibodies can be of different classes or isotypes as based on their heavy chain Fc 
regions (Mix et al., 2006). The different isotypes have different structural and 
chemical properties, which explains their specific and diverse roles in the immune 
system (Schroeder and Cavacini, 2010). IgM is one such class of antibodies which 
has been unique, right from their discovery as the horse anti-Type I Pneumococcus 
polysaccharide antibody which was heavier (19S) than the (7S) rabbit anti-Type III 
Pneumococcus polysaccharide antibody (Heidelberger and Pedersen, 1937). Due to 
its larger size it was called ‘macroglobulin’, leading to its nomenclature as IgM, 
while the 7S isotype is what we now call IgG (Cohen, 1965). Elevated levels of 
IgMs were detected by Jan Gösta Waldenström (Waldenstom, 1944) in a condition 
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which is now called Waldenström’s Macroglobulinemia (Neparidze and 
Dhodapkar, 2009) and is now classified (McMaster and Landgren, 2010) under a 
wider group of diseases called IgM monoclonal gammopathy of undetermined 
significance (IgM-MGUS). Today it is known that IgMs are expressed as 
membrane-bound monomers (~180 kDa) on all naïve B1 cells even in the absence 
of an apparent antigen and constitute the major component of the ‘natural’ or 
‘innate’ antibodies. So they are the first isotype of antibodies to be produced prior 
to the onset of class switch recombination (CSR) and somatic hypermutation 
(SHM).  As a consequence their affinity is often lower than that of other isotypes. 
Upon antigenic stimulus (immunization or infection) IgMs are thus the first class 
of antibodies produced during a primary antibody response, hence forming the first 
line defense against invading pathogens and maintaining tissue homeostasis by 
regulating the clearance of cellular debris. Such IgMs are usually secreted as 
pentamers with a J chain and are around 970 kDa in size (Saltzman et al., 1994) or 
hexamers without the J chain and are around 1.15 MDa in size (Randall et al., 
1990). The polymeric structure of IgM (Perkins et al., 1991), as seen in Fig. 3 
illustrates 10 antigen binding sites, bestowing higher valency to IgMs and allowing 
them to bind to antigens with a wide range of avidities. This makes IgMs more 
efficient than other isotypes in causing agglutination or clumping, which facilitates 
the removal of foreign pathogens or antigens. The lower affinity and higher 
valency makes IgMs polyreactive, and enables them to recognize antigens with 
repeating epitopes, like bacterial surface polysaccharides (Cutler et al., 2007). Thus 
IgMs play a significant role in the immune system (Vollmers and Brändlein, 2006) 
and their properties have been utilized in immunotherapy of a wide range of 
diseases like arthritis (Odani-Kawabata et al., 2010), graft-versus-host diseases 
(Godder et al., 2007; Waid et al., 2009), neurological disorders (Rodriguez et al., 
2009) or infectious diseases (Lu et al., 2011). The natural immunity of humans 
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Fig. 3. Structure of pentameric human immunoglobulin M with J chain. This image was 
generated using the PDB file 2RCJ (Perkins et al., 1991) with the Jmol viewer (version 12.0.18). 
 
against cancer cells consists almost exclusively of IgMs (Schwartz-Albiez et al., 
2009; Vollmers and Brändlein, 2009) and so they have also been used in 
immunotherapy for cancers (Azuma et al., 2007; Bieber et al., 2007; Beutner et al., 
2008). Interestingly IgMs have also been proposed as AIDS vaccines (Yang, 
2009).  
 
Infact, the first monoclonal antibody, Sp1 generated by the first hybridoma cell 
line was also an IgM (Köhler and Milstein, 1975). However IgMs remain to be the 
least studied and most enigmatic of all the isotypes. This is mainly due to the 
considerable differences in biochemical and structural properties of IgMs with 
respect to the other isotypes which makes it difficult to purify and study them by 
standard methods well established for the other isotypes. Due to their polymeric 
nature IgMs are around a megadalton in size and hence less soluble. So they tend 
to aggregate and are prone to precipitation at lower temperatures. Gel filtration 
chromatography is not suitable to purify IgMs, as it is based on diffusion and IgMs 
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with very low D (diffusion coefficient) values around 3.2±1.4 x 10-7 cm2/s 
(Saltzman, 1994) reduce the capacity and resolution of the method. IgMs are 
denatured by extreme pH thus making affinity chromatography difficult. Solubility 
is also reduced at low conductance, thus making ion exchange chromatography 
unsuitable. Precipitation at low conductance was exploited in the method of 
euglobulin precipitation (García-González et al., 1988), based on which the 
technique of euglobulin adsorption chromatography (Bouvet et al., 1984) was 
developed. However, the method has problems like non-specificity leading to 
contamination with other co-precipitated proteins and low efficiency resulting in 
substantial loss of sample. Strong hydrophobic surfaces also denature IgMs thus 
ruling out hydrophobic interaction chromatography as an option for IgM 
purification. Furthermore IgMs do not bind well to protein A or G and hence they 
cannot be affinity purified like other isotypes, using these immunoglobulin-binding 
bacterial proteins (Ey et al., 1978). Protein L (Björck, 1988) does bind to IgMs 
with κappa-I type of light chain (Nilson et al., 1993), but it also binds to other 
isotypes with suitable light chains types (De Château et al., 1993) and hence is not 
useful for specific purification of IgMs from serum. Thus the unique biochemical 
and structural properties of IgMs makes them difficult to purify and study by 
standard methods established for other isotypes (Mahassni et al., 2009; Gagnon, 
2009). The growing importance of IgMs and the difficulties in their purification 
called for effective yet simple methods for their purification. This would allow 
more detailed studies of their properties and functions and help to improve the 
availability and effectiveness of IgMs in various biological and medical 
applications. Hydroxyapatite (HA) column chromatography has been long used for 
purification of proteins by chromatography (Hjerten et al., 1956) and has found 
various applications in protein purification (Cummings, 2009). IgMs being more 
charged than IgGs bind to HA much more strongly than IgGs and contaminants, 
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thus HA column chromatography is a simple method for quick and easy 
purification of IgMs under mild conditions with a high recovery rate, yielding 
substantially purified, immunoreactive antibody in concentrated form (Henniker 
and Bradstock, 1993; Aoyama and Chiba, 1993). Upon selective desorption on 
ceramic hydroxyapatite (CHT), most IgMs typically elute as a characteristic peak 
between 200 and 300 mM phosphate with gradient elution (Gagnon et al., 2008), 
thus making it a standard method which needs minimal optimization. The 
compatibility of HA chromatography with the properties of cell culture 
supernatants allows the direct application of the hybridoma supernatants to the 
column with minor modifications but without sample dilution, thus reducing the 
overall time required. 
 
Many of the mAbs of the Wuerzburg Hybridoma Library are also IgMs. Two such 
IgMs used in this doctoral work were produced by the cell lines na21 and ab52. 
Based on the above advantages, we here applied HA based selective desorption 
chromatography to purify the IgM, produced by the cell line na21 which was 
generated by serum-free hybridoma culture as described herein. This thesis will 
further describe the materials, methods and results from the experiments aiming to 
purify, characterize several mAbs and their target antigens. 
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Chapter 2.   MATERIALS  
2.1 Fly strains: 
Drosophila melanogaster commonly known as ‘fruit fly’ was used as the model 
organism for this doctoral research work. Canton S available in the department was 
used as the wild-type strain unless otherwise mentioned. For the confirmation of 
the ab52 antigen, the EPS-15 mutant strain was kindly provided by Hugo Bellen. 
The genotype was:                      yw ;     eps15Δ29       ;  +     
                                CyO, twi>GFP    + 
Other fruit fly species tested for presence of the na21 antigen were obtained from 
the Drosophila Species Stock Center, San Diego. The species tested were: D. 
simulans, D. ananassae, D. willistoni, D. sechellia and D. yakuba. 
 
2.2 Buffers and reagents 
 
2.2.1  SDS-PAGE  
   2.2.1.1 Mini Protean™ (BioRad®) electrophoresis system: 
Table 1. Resolving gel (reagents for two mini gels) 
Table 2. 5% Stacking gel (reagents for two mini gels) 
Gel percentage 12.5%      15% 
Reagents      (ml)      (ml) 
30% Acrylamide: bisacrylamide (29:1) 3.125  3.75 
1.88 M Tris/HCl, pH 8.8 1.5 1.5 
dH2O 1.375 0.75 
0.5% SDS 1.5 1.5 
10% APS 0.04 0.04 
TEMED 0.006 0.006 
                                  Reagents (ml) 
30% Acrylamide: bisacrylamide (29:1) 0.5  
0.635 M Tris/HCl, pH 6.8 0.6 
dH2O 1.3 
0.5% SDS 0.6 
10% APS 0.03 
TEMED 0.004 
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SDS PAGE Running  125 mM Tris (15.142 g)    
 buffer (10x)   960 mM Glycine (72.07 g) 
0.5% (w/v) SDS (5 g) 
pH adjusted to 8.9 and final volume was made 
upto 1 liter by dH2O (stored at room temperature) 
 
Lämmli buffer 120 mM Tris   (1.2 ml of 1 M stock, pH 6.8)  
(2x)   20% (v/v) Glycerol  (2 ml of 100% Glycerol) 
   4% (w/v) SDS   (4 ml of 10% stock) 
   0.02% (w/v) Bromophenol blue  (0.2 ml of 1% stock)  
   5.0% (v/v) β-Mercaptoethanol  (0.5 ml added fresh) 
   Final volume made upto 10 ml with dH2O 
 
2.2.1.2 Novex Mini XCell™ (Invitrogen®) electrophoresis system: 
 Gels   : precast Bis-Tris NuPAGE™ gels. 
 Running buffer : 1x MES/ MOPS SDS running buffer from supplier. 
 Loading buffer : 1x LDS buffer with 1x Reducing agent from supplier. 
 
2.2.1.3 Tricine SDS-PAGE 
Components 7.5% 10% 12.5% 15% 17.5%  
30% Acrylamide (Rotipur Gel A) 7.5 ml 10.0 ml 12.5 ml 15.0 ml 17.5 ml 
2% Bisacrylamide (Rotipur Gel B) 3.0 ml 4.0 ml 5.0 ml 6.0 ml 7.0 ml 
1.5 M Tris-HCl, pH 8.8 7.5 ml 7.5 ml 7.5 ml 7.5 ml 7.5 ml 
dH2O 11.5 ml 8 ml 4.5 ml 1.0 ml - 
Solution degassed for 5 min 
10 % SDS (w/v) 300 µl 
10 % APS (freshly made)  200 µl 
TEMED                                   20 µl 
Table 3. Resolving gel (8.5 x 16 x 0.1 cm = 30 ml) 
 
Overlaid with dH2O and allowed to polymerize for ~15 min. 
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Components 5% Stacking gel  
30% Acrylamide 2.5 ml  
2% Bisacrylamide 1.0 ml  
0.5 M Tris-HCl, pH 6.8 3.7 ml  
dH2O 7.5 ml  
Solution degassed for 5 min. 
10% SDS 150 µl  
10% APS 200 µl  
TEMED              10 µl 
Table 4. Stacking gel (1.5 x 16 x 0.1 cm = 15 ml) 
 
Allowed to polymerize for ~10 min. 
 
Tricine Sample Buffer:  
 Tris    0.1 M  1 ml of 0.5 M stock 
 SDS    4%  2 ml of 10% stock 
 Glycerine   20%  1 ml of 99% stock 
 β-Mercaptoethanol  0.8 M  0.3 ml of 14M stock 
 Bromophenol blue  0.025%  0.1 ml of 1% stock 
 dH2O    0.6 ml to make volume upto 5ml  
2.2.2 Western Blotting: 
Transfer buffer (1x) 25mM Tris (6.04 g) 
         150 mM Glycine (22.52 g)  
    20% Methanol (400 ml) 
pH was adjusted to 8.3 and volume made upto 2 liter 
with dH2O (stored at 4°C)  
Washing buffer  100 mM Tris (12.11 g) 
(1x TBST)   1.5 M NaCl (87.66 g) 
    0.5% Tween 20 (5.0 ml) 
    pH adjusted to 7.6 and volume made upto 1 liter with  
    dH2O to get the 10x stock.  
Blocking solution  1 g Non fat dry milk powder dissolved in 20 ml of 
(5% NFDM)   1x TBST (per mini blot), briefly boiled, filtered. 
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Development method  ECL™ Western blot detection kit (Amersham GE®) 
 
Detection system  Chemiluminiscence produced by the HRP coupled to the  
    2° Ab in presence of the luminal substrate was captured  
    as exposures on X-Ray films which were developed  
    using the developer and fixative solutions (Kodak).  
 
2.2.3 Coomassie® Staining: 
   2.2.3.1 CBB R250: 
• Staining   MeOH  45%  450 ml  
     solution   Acetic acid   10%  100 ml 
    dH2O   45%  450 ml  
    CBB R250  0.25% 2.5 g 
    The mixture was constantly stirred for 3 hrs for proper  
    mixing and then filtered through filter paper. 
 
• Destaining solution MeOH  30%   300 ml 
   Acetic acid   10%   100 ml  
Total volume was made upto 1liter with dH2O 
• Drying solution  MeOH  20%    200 ml 
Glycerol   3%   30 ml 
Total volume was made upto 1liter with dH2O 
 
 2.2.3.2 Colloidal CBB G250: 
 
• Fixative  ortho-phosphoric acid (H3PO4) 0.85 %  (1.5 ml of 85% stock) 
MeOH    20%       30 ml 
   Final volume was made upto 150 ml with dH2O 
• Staining   MeOH  20%  30 ml  
     solution   dH2O   65%  90 ml  
    R250 solution 20%  30 ml Roti®-Blue 
    Roti®-Blue was added periodically while stirring for 3 hr.  
 
• Destaining solution MeOH  25%   250 ml 
    Final volume was made upto 1 liter with dH2O 
 
2.2.4 Silver Staining: (all solutions should be made fresh) 
• Fixative   40% EtOH (20 ml) 
10% Acetic acid (5 ml) 
Final volume made upto 50 ml by dH2O 
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• Wash   30% EtOH (15 ml) 
Final volume made upto 50 ml by dH2O  
• Sensitizer  0.02% Na2S2O3 (0.01 g) 
Final volume made upto 50 ml by dH2O  
• Silver solution  0.2% AgNO3 (0.1 g) 
Final volume made upto 50 ml by dH2O (cooled to 4ºC 
before use) 
• Developer  3% Na2CO3 (3 g) 
0.05% Formalin (50 µl of 35% Formaldehyde) 
Final volume made upto 100 ml by dH2O  
• Stopper   0.05 M EDTA (0.931 g) 
Final volume made upto 50 ml by dH2O  
• Storage    1% Acetic acid (0.5 ml Hac) 
Final volume made upto 50 ml by dH2O 
2.2.5 Destaining of silver stained gels: (all solutions should be made fresh) 
• Solution A  3.7 g of NaCl and 3.7 g CuSO4 in 45 ml of dH2O by  
    constant stirring to get an aqua marine solution, while  
    constantly stirring add 25% NH4OH to form a light  
    bluish ppt, keep adding drop by drop till ppt turns dark  
    blue and more till the ppt slowly dissolves to yield a  
    clear, transparent dark blue solution. 
 
• Solution B  0.01 g Na2S2O3 in 50 ml dH2O 
 
• Destaining solution Mix equal volumes of solutions A and B just before use. 
 
• Stopper   10% Acetic acid 
 
• Storage    1% Acetic acid  
2.2.6  Immunoprecipitation (IP) 
IP lysis buffer (1X) 25 mM Tris (1.514g) 
    0.15 M NaCl (4.383g) 
    2 mM EDTA (0.372g) 
   2 mM EGTA (0.38g) 
   10% Glycerol (50 ml) 
    0.1% NP-40 (0.5 ml) 
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pH adjusted to 7.6 and final volume was made to 500 ml 
by dH2O. To 10ml of the above IP buffer 1 tablet of 
protease inhibitor cocktail (Complete Mini™, Roche®) 
was added freshly before use and buffer was cooled to 
4ºC before use. 
 
2.2.7 Protein precipitation 
 
   2.2.7.1 TCA precipitation: 
• TCA stock  72% (w/v) TCA 
• Acetone   ≥99% pure 
 
   2.2.7.2 Chloroform Methanol precipitation: 
• Chlorofom  ≥99% pure  
• Methanol  ≥99% pure 
 
   2.2.7.3 Ethanol precipitation: 
• Ethanol   ≥99% pure  
 
2.2.8 Hybridoma cell culture: 
• HT medium  20% v/v medium 199  
     70% v/v RPMI 1640 with Glutamax  
     10% v/v fetal bovine serum (FBS),  
     1x HT (hypoxanthin-thymidin) cocktail  
     1x Anti-Anti (antimicrobial agent) 
 All media components (Invitrogen) were mixed freshly before use and filter 
sterilized through a 0.2 µm filter (Whatman) 
 
• Staining solution Trypan Blue (Sigma) 
 
• Serum free medium  50% v/v HT medium without FBS  
    40% HEP (PAA Laboratories) 
    10% v/v HCS (PAA Laboratories) 
2.2.9 Capture ELISA for Isotyping: 
• 1xPBS   10 mM phosphate buffer, 150 mM NaCl, pH 7.4 
 
• Washing buffer  1x PBST (0.05% Tween 20) 
 
• Substrate   5-Aminosalicylic Acid (1 mg/ml) in 0.02 M   
     sodium phosphate, pH 6.8 + 0.01% H2O2 (v/v) 
• Stopping solution   3 N NaOH 
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2.2.10 Subcellular fractionation: 
• Homogenization buffer 50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM  
     EGTA final pH 7.4 supplemented with 1 tablet  
     (per 10 ml buffer) of protease inhibitors mix  
     (Complete Mini™, Roche) 
 
2.2.11 Two dimensional electrophoresis (IEF/SDS): 
 
• Sample homogenizing mix: 
 Zoom® 2D Protein Solubilizer 1 or 2            91 µl    
 1 M Tris Base      0.5 µl     
 100x Protease Inhibitor Cocktail (Roche®)  1 µl    
 2 M DTT       1 µl  
 ddH2O       2 µl  
 
• Alkylating agent: DMA (N,N-Dimethylacrylamide) 
 
• Strip rehydration mix: 
 Zoom® 2D Protein Solubilizer 1 or 2           135-156 µl   
 2M DTT       1 µl    
 Ampholytes 3-10 (Servalyte™, Serva)   2 µl   
 ddH2O       5 µl 
 1% Bromophenolblue     trace 
 Sample homogenate                                          1-22 µl 
 Final volume                    165 µl 
 
• Equilibration solution (400 µl per strip):  
 4x NuPAGE™ LDS Sample Buffer   final conc 1x  
 10x NuPAGE™ Reducing Agent   final conc 1x   
• Alkylation solution: 
 1x NuPAGE™ LDS Sample Buffer   400 µl    
 125 mM Iodoacetamide     0.0093 g 
 
• Strip overlaying solution : 0.5% agarose solution in SDS-PAGE running 
 buffer  
 
• SDS-PAGE running buffer: 1x  MOPS/MES 
 
2.2.12 Two dimensional electrophoresis (NEPHGE/SDS): 
• Tube gels of length 11cm and diameter 3mm were casted overnight with: 
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        9 M Urea  
       4% acrylamide  
       2.5% NP-40  
       5% ampholytes pH 2-11    
       0.03% APS  
       0.2% TEMED  
 
• Sample loading buffer 1   9.5 M Urea  
       0.5% SDS  
       5% β-mercaptoethanol  
       2% ampholytes pH 2-11 
 
• Sample loading buffer 2   9.5 M Urea  
       5% NP-40  
       5% β-mercaptoethanol  
       2% ampholytes pH 2-11 
 
• Sample overlaying solution  6 M Urea  
       5% NP-40   
       1% ampholytes pH 2-11 
 
• Cathode buffer    20 mM NaOH  
 
• Anode buffer    10 mM H3PO4 
 
• SDS sample buffer    60 mM Tris-Cl pH 6.8  
       2% SDS  
       5% β-mercaptoethanol  
       10% Glycerin 
 
• Tube gel overlaying solution  1% Agarose in SDS sample buffer 
 
• 1x SDS-PAGE running buffer  Tris 3 g     
       Glycine 14.4 g 
       SDS 1 g  
       Volume made upto 1 liter with dH2O 
2.2.13 Grape juice agar for egg laying: 
1.5 g agar dissolved in 40ml dH2O and boiled briefly + 1.5 g sucrose dissolved in 
10ml of pure grape juice warmed upto 60ºC and mixed to the agar solution + 0.5ml 
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glacial acetic acid. Total volume ~ 50ml poured on empty petri plates and allowed 
to solidify under a hood for 5 minutes. Can be stored at 4ºC for upto a week or 
used for egg laying. 
2.2.14 Cryosectioning and Immunostaining 
• Fixative: (made freshly before use) 
 
o 4% PFA: 2g dissolved initially in 25 ml dH2O by heating upto 60ºC with 
constant stirring 
o 100 µl of 1 M NaOH was added and the solution turned clear 
o On complete dissolution it was cooled to RT 
o 19 ml of (1/15) M Na2HPO4 and 5 ml of (1/15) M K2HPO4 were added  
o pH adjusted to 7.4 by (1/15) M K2HPO4 and final volume made to 50 ml 
o Solution was chilled on ice before use 
 
• Drosophila Ringer   NaCl  7.48g 
KCl  0.35g 
CaCl2   0.2g 
Na2HPO4  0.105g 
KH2PO4  0.048g 
Final volume made upto 1liter with dH2O  
• Wash and Cryoprotectant 25% Sucrose (25 g in 84 ml of above Ringer  
solution) 
 
• Embedding medium      16% CMC (1.6 g in 10ml of dH2O)  
• PBS (10x)   14.8 g Na2HPO4 
     4.3 g KH2PO4 
     72 g NaCl 
pH adjusted to 7.4 and final volume made to 1liter 
by dH2O  
2.2.15 Adult brain whole mounts: 
• Fixative     made freshly as described above in section 2.2.11. 
 
• Drosophila Ringer  as described above in section 2.2.11. 
• Wash buffer   1x PBST (0.5% Triton X-100). 
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• Blocking solution   5% Normal-Goat-Serum in 1x PBST. 
2.2.16 Larval brain whole mounts: Same as above only with 0.3% Triton X-100. 
 
2.2.17 Larval NMJ dissection: 
• Ca2+ free saline (should be pre-cooled to 4°C): 
     NaCl   7.6 g 
     Sucrose  12.32 g 
     KCl  0.37 g 
     MgCl2 0.38 g 
     HEPES 1.3 g 
     EDTA 0.19 g 
     Final volume madeup to 1liter with dH2O. 
 
• Fixative     made freshly as described above in section 2.2.11. 
 
• 2x PEM buffer: 
PIPES  30.24g in 100ml dH2O  (dissolves at pH 7.0) 
EGTA   0.76g in 100ml dH2O  (use conc. NaOH to adjust pH to 7.0) 
MgSO4   0.24g in 100ml dH2O  (No pH adjustment) 
 
20 ml PIPES + 20 ml EGTA + 20 ml MgSO4 + 40 ml dH2O = 100 ml of 2x 
PEM buffer 
 
• Blocking solution (should be freshly prepared): 
1x PBS     4.64 ml 
BSA (2%)    100 mg 
Triton X-100 (0.2%)   10 µl 
Normal Horse/Goat Serum (5%) 250 µl 
Final volume made upto 5ml. 
 
• Wash buffer     1x PBST (0.1% Triton X-100) 
2.2.18 Proteoliposome formation: 
• Phospholipid solution   20 mg Soyabean PC (Sigma) in 1ml  of 
      Chloroform:MeOH (2:1) + 300 µl of   
      1 mg/ml Rhod-PE (Avanti Polar Lipids Inc.) 
2.2.19 Hydroxyapatite column chromatography: 
• Low salt (buffer A)   10 mM sodium phosphate pH 6.7 
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• High salt (buffer B)   500 mM sodium phosphate pH 6.7 
 
2.2.20 Ion exchange chromatography: 
 
• Low salt (buffer A)  30 mM HEPES ph 7.4, 100 mM NaCl, 4 M Urea,  
     1 mM EDTA, 1 mM EGTA 
 
• High salt (buffer B)  same as buffer A except 1 M NaCl 
2.3 Protein Mr marker 
 
Fig. 4. Separation profile of the marker. 
 
2.4 Antibodies: 
    2.4.1 Primary antibodies: 
 
Table 5. Details about name, target proteins, dilution and sources of 1° Abs used. 
1° Ab Target protein  Dilution for WB Sources* 
3c11 Synapsins 1:100 WHL 
na21 Protein X? 1:10 WHL 
ab52 EPS-15 1:10 WHL 
ab49 CSP 1:200 WHL 
nc46 SAP-47 1:200 WHL 
aa2 EPS-15 1:2 WHL 
8C3 Syntaxin 1:1000 DSHB 
BB70 HSP-70 1:1000 Axxora GmbH 
Anti VAMP Clone 10.1 VAMP 1/2/3 1:3000 SYSY 
ab5930 Mouse IgM µ chain 1:5000 Abcam 
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*WHL = Wuerzburg Hybridoma Library, Wuerzburg, Germany. 
  DSHB = Developmental Studies Hybridoma Bank, Iowa, USA. 
  SYSY = Synaptic Systems, Goettingen, Germany. 
 
2.4.2 Secondary antibody: 
 
• α-mouse IgG-HRP (Biorad®) used at 1:7500 in 1x TBST for WB 
• Biotinylated α-mouse IgG (Vector Labs) used at 1:200 in 1x PBST for IHC 
• α-mouse IgG-Cy3™ (Invitrogen®) used at 1:1000 in 1x PBST for IHC 
• α-mouse IgG-AlexaFluor488™(Invitrogen®) used at 1:1000 in 1x PBST for IHC 
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Chapter 3.   METHODS 
3.1  Fly rearing: Flies were reared in large (10 x 4.5 cm) or medium (9 x 3.5 
cm) sized vials and maintained at 25°C with 60-70% relative humidity and 14/10 
hr light/dark cycle. Flies were reared on food which had the following 
composition: 
Water   39 liter  Yellow cornmeal     2.85 gm 
Yeast   675 gm Light malt extract (dehydrated)  1.8 gm 
Soy flour   390 gm  Light corn syrup     3 liter 
Agar    225 gm  Propionic acid     0.188 liter  
 
3.2  Collection of large amount of fly heads: For collection of large amount of 
fly heads, flies stock was expanded by frequently flipping stocks to new vials and 
having more progeny. Large sized polylpropylene cages 60 x 60 x 60 cm were also 
used for large scale fly culture. Adult flies were anesthetized with CO2 or cold 
(4°C) treatment and collected in 50ml falcon tubes which were then snap frozen by 
dipping the in liquid N2. Frozen flies could be stored at -80°C. To isolate the heads, 
frozen flies were vigorously vortexed to separate all jointed body parts and passed 
through a stack of two sieves. The upper sieve with 800µm mesh size retained 
thorax and abdomen while the lower sieve with 500µm mesh size retained the 
heads and smaller body parts passed through. Thus the isolated heads were 
collected from the lower sieve and used for further experiments. 
 
3.3  Hybridoma cell culture and mAb production: Hybridoma clones were 
generated as described earlier (Hofbauer, 1991; Hofbauer et al., 2009). For mAb 
production, cryopreserved hybridoma cell lines were thawed slowly back to room 
temperature, diluted to 9 volumes of freshly made HT medium followed by 
sedimentation of  cells by centrifuging at 1000 rpm for 2 minutes. The supernatant 
was discarded and the pellet was gently resuspended in 2 ml of HT medium and 
incubated in 24 well Nunclon™Δ plates (Nunc). 50 µl of FBS was added per well 
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to facilitate the initial growth of the thawed cells. Growth of cells was monitored 
daily under inverted microscope (Zeiss) and after 2-3 days, when cells proliferated, 
the cell suspension was used to inoculate 5 ml HT medium in 50 ml T-flasks 
(Grenier Bio) and further cultured for 2 days. Thereafter fresh medium was 
provided and after 2 more days, cell density was determined by Trypan Blue 
(Sigma) exclusion staining of cell suspension using a Neubauer-counting chamber 
(GLW). When the cell density reached ~105 cells/ml and the medium color turned 
yellow, supernatant was withdrawn, centrifuged at 2000 rpm for 5 min to pellet all 
cells and the cell-free supernatant was tested for the presence of antibodies to find 
the optimal dilution for a reliable signal in western blots and/or 
immunohistochemistry. Upon detection of an antibody signal, the antibody 
producing cells were further cultured for continued antibody production until the 
cell density reached ~106 cells/ml. At this stage they could be either split into more 
flasks or used to inoculate larger T-flasks (250 ml, 75 cm2, Grenier Bio). 
Supernatant from larger flasks was withdrawn every 3rd day.  
 
3.4  Production of serum free supernatant: For production of serum-free 
supernatant, concentrations of fetal bovine serum (FBS) were gradually lowered 
from 10% to 0% in 10 steps. At each step, concentrations of Hybridoma Express 
Plus (HEP) medium and Hybridoma Cloning Supplement (HCS) were increased by 
4% and 1%, respectively, and cells were cultured for 3 days. After a month, the 
cells were growing in serum-free medium (50% HT medium, 40% HEP, 10% v/v 
HCS). For large scale production, serum-free cultures with a cell density of ~106 
cells/ml were used to inoculate a two-compartment bioreactor, CELLine CL1000 
(Integra Biosciences). The cells grew in 20 ml serum-free medium in the lower 
compartment separated by a 10 kDa semi-permeable cellulose acetate membrane, 
from 1 liter normal HT medium (with FBS) in the upper compartment. This 
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allowed diffusion of nutrients and small signaling molecules while preventing 
contamination of the culture by serum proteins. Serum-free supernatant was 
withdrawn every 7th day.  
 
3.5  Cryopreservation of  cell lines: For cryopreservation, 6 ml of cell culture 
(late log phase) were centrifuged at 1000 rpm for 2 minutes and the cells were 
gently resuspended in HT medium supplemented with additional 10% FBS and 
10% DMSO (cell culture tested, Sigma). The cells were frozen at -80oC over night 
and thereafter stored in liquid nitrogen. 
 
3.6  Characterization of the mAbs: For the characterization of mAbs their 
isotype was determined by capture ELISA using the ISO2-KT (Sigma) mouse 
monoclonal isotyping kit following the manufacturer’s instructions. 5-
Aminosalicylic acid (Sigma) was used as substrate (1mg/ml) in 0.02 M sodium 
phosphate buffer (pH 6.8) with 0.01% H2O2 v/v. The isotype was also confirmed 
by immunoassay based Isoquick Strips (Envirologix) following the manufacturer’s 
instructions. For storage of the monoclonal antibodies, suitable sized aliquots of 
the culture supernatant were snap frozen in liquid nitrogen and stored at -20°C. 
However in case of IgM antibodies, which tend to aggregate upon repeated 
freezing and thawing, they were either stored as small frozen aliquots or larger 
aliquots were stored at 4°C by adding 0.02% NaN3 (w/v) as antimicrobial agent. 
 
3.7  Protein quantification: Protein concentrations of samples were determined 
by the BCA Protein Assay Kit (Pierce®) following manufacturer’s instructions. 
A562 was measured using the Sunrise™ Basic (Tecan) 96-well microplate reader. 
 
3.8  Protein precipitation: 
3.8.1  TCA precipitation: To a protein sample solution, 1/5th volume of 72% 
(w/v) TCA stock solution (e. g. 0.25 ml TCA stock + 1 ml sample) was added and 
mixed well by brief vortexing. The mixture was incubated on ice for 30 min 
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followed by centrifugation at 14000 rpm for 30 min at 4oC. The supernatant was 
discarded and the pellet was washed with 0.5 ml of ice-cold Acetone. Sample was 
again centrifuged at 14000 rpm for 10 min at 4oC and supernatant was discarded. 
The pellet was air-dried at 37oC for 5 min (or till no more acetone was visible) and 
was ready to be dissolved in Lämmli buffer for SDS-PAGE. 
 
3.8.2 Chloroform Methanol precipitation (for removal of salts & detergents): 
To the protein sample (say 0.1 ml) 4 volumes (0.4 ml) of Methanol was added and 
mixture was mixed well by vortexing for 1 min. Then 1 volume (0.1 ml) of 
Chlorofom was added followed by vortexing as above and addition of 3 volumes 
(0.3 ml) of ddH2O again followed by vortexing as above. The sample was 
centrifuged at 14000 rpm for 1 min at RT to get a protein layer at the interface 
between the upper aqueous and lower organic phases. Upper aqueous phase was 
discarded and 4 vol (0.4 ml) of Methanol was added, followed by vortexing as 
above. The sample was again centrifuged at 14000 rpm for 2 min at RT and as 
much supernatant as possible was removed without disturbing the pellet. The pellet 
was air-dried at 37oC for 5 min (or till no more liquid was visible) and was ready to 
be dissolved in Lämmli buffer for SDS-PAGE. 
 
3.8.3 Ethanol precipitation: To protein sample solution 10 volumes of pre-
chilled (-20oC) Ethanol was added and mixed well by brief vortexing. The mixture 
was incubated at -20oC for 3 hr followed by vortexing and centrifugation at 14000 
rpm for 5 min at 4oC. The supernatant was discarded and the pellet was washed 
with 70% Ethanol followed by centrifugation at 14000 rpm for 2 min at 4oC. The 
supernatant was discarded and the pellet was air-dried at 37oC for 5 min (or till no 
more liquid was visible) and was ready to be dissolved in Lämmli buffer for SDS-
PAGE. 
 
3.9 Sub-cellular fractionation of fly head: Frozen heads collected from the lower 
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sieve as described earlier in section 4.2 were pulverized in a mortar-pestle, which 
was prechilled to -80°C. The powder was dissolved in homogenization buffer 
(section 2.2.10) 10 ml per g of fly head. The sample was thoroughly mixed to get a 
uniform homogenate which was then incubated on ice for 5 minutes. Thereafter it 
was spun twice at 13000 rpm for 15 min each, at 4°C to pellet the exoskeleton, cell 
debris, nuclei. The ‘post-nuclear supernatant’ (S1) was re-spun in a 60Ti rotor, 
using an L8 ultracentrifuge (Beckman Coulter®) at 100000g for 1 hr at 4°C to get 
the ‘cytosolic fraction’ as the supernatant (S2) and the ‘total membrane fraction’ as 
the pellet (P2) which were then tested on Western blots. Anti HSP70 antibody 
(BB70, Axxora GmbH) was used as a cytosolic marker (1:1000) while anti-
Syntaxin antibody (8C3, DSHB) was used as a membrane marker (1:1000). 
 
3.10 Subfractionation of total membrane fraction: The total membrane pellet 
was resolved by density gradient centrifugation. 5-25% continuous gradient was 
prepared in 13.2ml Ultra-Clear® polyallomer, open top tubes (Beckman Coulter®) 
using a gradient mixer (made in house at workshop) with 25% and 5% sucrose 
solutions (w/v) in homogenization buffer (section 2.2.10). Total membrane pellet 
(P2) from 10 ml of S1 (10000 fly head equivalents) was resuspended in 0.5 ml of 
the same homogenization buffer by mild homogenization and pipetting and then 
overlaid upon the gradient. The samples were centrifuged in a SW41Ti rotor, using 
an L8 ultracentrifuge (Beckman Coulter®) at 39000 rpm (~ 187813 g) for 4.5 hr at 
4°C. Fractions were carefully withdrawn from top gradually by a pipette. 
 
3.11 Generation of proteoliposomes: 
3.11.1 By simple dilution below CMC: For generation of proteoliposomes P2 was 
dissolved in 1% (w/v) CHAPS followed by ultracentrifugation at 100000g for 1 hr 
at 4°C to get supernatant (S3) and a pellet (P3). S3 was then diluted 10 times to 
bring the CHAPS concentration to 0.1% (w/v) which is below its critical micelle 
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concentration (CMC). Any proteoliposome formed were separated as pellet (P4) by 
another round of ultracentrifugation at 100000g for 1 hr at 4°C.  
3.11.2 By gel filtration chromatography: The total membrane pellet P2 was 
dissolved in 3% (w/v) CHAPS followed by ultracentrifugation at 100000g for 1 hr 
at 4°C to get supernatant (S3) and a pellet (P3). S3 was used to dissolve 
phospholipids (Soybean phosphatidylcholine, Sigma) containing Rhodamine-	  
Phosphatidylethanolamine (Avanti® Polar Lipids Inc.) as a fluorescent marker. The 
sample was resolved by gel filtration chromatography, through a Sephadex™ G50 
(GE) column to separate the proteoliposomes from the monomeric detergent 
molecules. Fractions eluted around the Rhodamine-PE peak were collected and 
analyzed by Western blot. 
 
3.12 Immunoprecipitation for enrichment of na21 antigen: CS fly heads were 
isolated as described earlier in section 4.2. Heads were homogenized in IP lysis 
buffer (1 ml per gm of fly head) in a prechilled glass homogenizer (Kontes). 
Homogenate was centrifuged at 13000 rpm twice for 15 mins each at 4ºC to get rid 
of the debris. 5 µl aliquot of the supernatant was stored at -20 ºC as an IP input 
control. To another aliquot undiluted mAb na21 was added (0.5 ml supernatant per 
ml of tissue lysate) and incubated for 3 hr with gentle rotatory mixing at 4ºC. 0.1 
ml of mAb 3C11 was added to 0.5 ml lysate as positive control. 0.1 ml of protein 
G agarose beads were washed with the IP lysis buffer for 15 min and then pelleted 
by a short spin. The mAb-lysate mixture was added to the beads and incubated 
overnight with gentle rotatory mixing at 4ºC. Next morning the beads were spun 
down at 13000 rpm for 3 min. Supernatant was discarded and beads were washed 
with 0.5 ml of IP lysis buffer. Washed beads were spun down and the supernatant 
was discarded. The beads were washed three times more as above and after the 
final wash 50 µl of 2x Lämmli buffer was added. 2 fresh heads were also 
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homogenized in 20 µl of 2x Lämmli buffer. All samples were incubated at 95ºC for 
3 min, followed by a short spin and then loaded on separate lanes of a 12.5% PAA 
gel and resolved by SDS-PAGE. 
 
3.13  Resolution of proteins by electrophoresis: 
3.13.1 One dimensional SDS-PAGE with self made gels: 1D SDS-PAGE was 
based on Lämmli’s system (1970). In brief, 0.75 mm thick, 12.5% PAA gel was 
casted as per recipe described in section 3.2.1.1. Samples were heat denatured at 
95ºC for 3 min, followed by a short spin and then loaded on separate lanes. The 
Mini Protean™ (Bio-Rad) apparatus was used. Samples were initially stacked at 60 
V and then upon entering the resolving gel, run at 100 V till the smallest (10 kDa) 
marker was ~1 cm above the bottom.  
 
3.13.2 One dimensional SDS-PAGE with pre-cast gels: 1 mm thick, 12% Bis-
Tris, precast gels (NuPAGE™, Invitrogen®) were used. Samples were prepared 
with the 4x LDS sample buffer and 10x Reducing agent (both Invitrogen®), both 
diluted to get final concentrations of 1x of each. Samples were heat denatured at 
70ºC for 10 min, followed by a short spin and then loaded on separate lanes. The 
X-Cell Sure Lock™ (Invitrogen®) apparatus was used and samples were resolved at 
100 V constant voltage till the smallest (10 kDa) marker was ~1 cm above the 
bottom. PageRuler™ Prestained Protein Ladder (Fermentas SM0671) was used as 
the molecular weight marker. 
3.13.3 Tricine SDS-PAGE: For better resolution of proteins in the lower 
molecular weight range, Tricine SDS-PAGE (Schägger and von Jagow, 1987) was 
used. In brief, 15% PAA gels were casted as per recipe described in section 2.2.1.3 
and fly eggs collected over grape-juice plates were homogenized in 2x Tricine 
sample buffer and resolved by SDS-PAGE. The stacking was done at 60 V 
followed by separation at a constant current of 25 mA. 
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3.13.4 Two dimensional electrophoresis (IEF/SDS): Proteins from fly head 
homogenate were resolved by 2D electrophoresis using the Zoom® 2D (Invitrogen) 
setup. In brief, 100 freshly isolated CS fly heads were homogenized in 100 µl of 
Zoom® 2D Protein Solubilizer 1 (Invitrogen) containing 1x protease inhibitors 
(Complete-Mini™, Roche®). The homogenate was then centrifuged at 13000 rpm 
for 15 min at 4°C, to get rid of exoskeleton, cell debris, and nuclei. 1 µl of 99% 
DMA (Sigma) was added to the post-nuclear supernatant and incubated on a rotary 
shaker at room temperature for 15 min to alkylate the proteins. Thereafter 1 µl of 2 
M DTT was added to quench any excess DMA and the sample was ready for 
loading. 25 µl of this homogenate, equivalent to 25 fly heads was mixed with 
rehydration mixture as follows: 
 Zoom® 2D Protein Solubilizer 1/2  137 µl  
 2 M DTT      1 µl 
 Bromophenolblue)     traces  
 Servalyte 3-10 pH ampholyte (Serva)   2 µl 
 Sample (homogenate)    25 µl 
 Final volume      165 µl 
 
Immobilized pH gradient (IPG) (Zoom®, Invitrogen) strips of pH range 3-10 were 
rehydrated overnight at 18°C with this sample following manufacturer’s 
instructions in the Zoom® IPG Runner™ cassette. Next day the sample in the 
rehydrated strips was resolved by isoelectric focusing (IEF) with a Zoom® Dual 
power supply unit (Invitrogen), while keeping the power limited to 0.1 W per strip 
and using the voltage regime shown in Table 6 (below). Thereafter the strips were 
incubated in the equilibration solution (1x NuPAGE™ LDS sample buffer with 1x 
NuPAGE™ Reducing Agent, both Invitrogen) and alkylation solutions (1x 
NuPAGE™ LDS sample buffer) with 125 mM IAA (Sigma) both for 15 min, 
respectively, with gentle shaking. Thereafter the strips were loaded in the IPG well 
of 4-12% Bis-Tris NuPAGE™ (Invitrogen) 2D PAA gel and overlaid with agarose  
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Table 6. Voltage regime for isoelectric focusing. 
 
solution (0.5% in 1x MOPS running buffer). The second dimension was run at 100 
V at 4°C to avoid over heating. Besides the molecular weight marker, 2 fly heads, 
freshly homogenized in 1x LDS sample buffer (Invitrogen) and heat denatured at 
70ºC for 10 min was also loaded on the 1D well, to serve as a 1D reference to the 
2D separation profile. After the 2nd dimension electrophoresis, proteins were either 
blotted from the gel onto nitrocellulose membrane for detection by Abs or the gel 
was stained to visualize the proteins. 
 
3.13.5 Two dimensional electrophoresis (NEPHGE/SDS): For resolution of 
larger amounts of proteins, Non-Equilibrium pH Gradient gel Electrophoresis 
(NEPHGE) was performed as per O’Farrell et al. (1977) with some modifications. 
In brief, glass tubes with length 12cm and inner diameter 3mm were rinsed with 
isopropanol and Na-Silicate followed by baking in an oven at 110°C for 1 hr. One 
end of the tubes was sealed with parafilm and tube gels of length 11 cm were 
casted overnight based on the recipe described in section 2.2.11. Soluble 
(cytosolic) fraction S2 was obtained as described earlier in section 3.8 and 
precipitated with 9 volumes of chilled acetone for 3 hours at -20°C. The sample 
was centrifuged at 10000 g for 10 min at 4°C to pellet the precipitated proteins. 
The supernatant was discarded, the pellet was air-dried and resuspended in sample 
loading buffer 1. Upon dissolution, an equal volume of buffer 2 (9.5 M Urea, 5% 
Step Voltage (V) Time (min) Equivalent Volthours (Vh) 
1 200 20 66.7 
2 450 15 112.5 
3 750 15 187.5 
4 750-2000 45 468.75 
5 2000 30 1000 
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NP-40, 5% β-mercaptoethanol, 2% ampholytes pH 2-11) was added. Sample 
equivalent to 100 heads was loaded on top of the tube gel. The sample was 
overlaid with 40 µl of overlaying solution (6 M Urea, 5% NP-40, 1% ampholytes 
pH 2-11). Electrophoresis was carried out in the Model 175 Tube Cell (Bio-Rad) 
setup at 200 V for 15 min, followed by 300 V for 30 min and finally at 400 V for 
120 min. 10 mM H3PO4 and 20 mM NaOH were used as anode and cathode 
electrophoresis buffers respectively. As a marker for highly basic proteins, 
Cytochrome C having a pI >11, was loaded on one of the tube gels as a control for 
the progress of the 1st dimension. At the end of the run, the NEPHGE gel with the 
sample was slowly withdrawn from the glass tube, equilibrated for 20 min with the 
SDS sample buffer (60 mM Tris-Cl pH 6.8, 2% SDS, 5% β-mercaptoethanol, 10% 
Glycerol) and overlaid with 1% agarose in SDS sample buffer on a 12% PAA gel. 
10 freshly homogenized fly heads were also loaded in an adjacent lane, to serve as 
a 1D reference to the 2D profile. Electrophoresis was carried out at 15 mA for 16 
hr. The tube gel with Cytochrome C was cut into 0.5 cm pieces and each piece was 
incubated overnight with 3 ml ddH2O at 4°C. The pH of the solutions was 
measured next morning to determine the pH gradient along the length of the gel. 
 
3.14  Western blotting: Proteins from gels (both 1D and 2D) were transferred 
onto 0.45 µm nitrocellulose membranes (Protran®, Whatman). Mini gels were 
transferred using the Mini Trans-Blot™ (BioRad®) wet-blot apparatus with 1x 
transfer buffer (Towbin et al., 1979), described in section 2.2.2 for 1hr at 100 V. 
Larger gels were transferred using the PerfectBlue™ (peqLAB) semi-dry blotting 
apparatus with the same buffer at 2 mA of current per cm2 of gel area for 1hr. 
Thereafter membranes were stained with Ponceau S (Sigma) solution to check for 
success of protein transfer. Membranes were then blocked with 5% milk solution at 
RT for 2 hr with gentle shaking. Thereafter membranes were incubated overnight 
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with primary mAb at suitable diluted (section 2.4.1) in 1x TBST at 4ºC with gentle 
shaking. Next morning membranes were incubated at RT for 30 min before being 
washed three times with 1x TBST, for 5 min each. Then membranes were 
incubated with corresponding secondary antibody and washed again as above. 
Finally membranes were incubated with the a freshly prepared mixture (1 ml per 
mini-blot) of the equal volumes of the two substrate reagents from the ECL™ kit 
(Amersham GE®) for 2 minutes in darkness. Thereafter excess detection reagent 
was decanted off and signals from the blot were captured as exposures on X-ray 
films for various exposure times in a dark room. The signal was developed using 
the development and fixation solutions (Kodak).  
 
3.15 Partial blotting of NEPHGE 2D gel followed by Western blot for 
detection of ab52 antigen: After 2DE, the gel was blotted for 20 minutes only, 
using the semi-dry blotting apparatus as described above in section 3.10.5. Due to 
the reduced time, only part of the protein content of the gel was transferred onto 
the membrane, while the rest was retained in the gel, which was then silver stained 
for MS compatibility as described later in section 3.14.3 The blot was then blocked 
and developed with ab52 (diluted 1:10) as described above in section 3.10.5. 
Overnight exposure was done to get a strong signal for the antigen along with 
weak non-specific signals on the blot, which would serve as landmarks for 
comparison with the silver-stained gel. Images of the over-exposed blot and the 
silver-stained gel were digitally superimposed with Photoshop (Adobe) to pinpoint 
the protein spot in the silver stained gel that corresponded to the signal in the 
Western blot. This spot was then excised and analyzed by mass spectrometry (MS) 
as described in Hofbauer et al., (2009). 
3.16  Staining of proteins in gels: 
3.16.1 Coomassie® R250 staining: After electrophoresis, the part of the gel to be 
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stained was cut out from the glass plates and washed in dH2O for 3 min. The gel 
was then incubated in Coomassie® Brilliant Blue R250 staining solution (section 
2.2.3.1) for 30 mins at RT. The dye was decanted for reuse and the gel was washed 
in dH2O for 2 mins. The gel was then incubated with destaining solution for 2 hrs 
at RT. Thereafter destaining solution was discarded and fresh solution was added 
and left overnight until the gel matrix was almost destained and only specific 
protein bands were visible in minimal background. The gel’s image was then 
stored (before any band was to be cut out or the gel was to be dried). For 
preservation, the gel was incubated in drying solution for 6-8hrs. Then it was 
wrapped with transparent cellophane sheets and dried under vacuum and heat. 
3.16.2 Coomassie® G250 staining: After electrophoresis, the part of the gel to be 
stained was cut out from the glass plates and washed in dH2O for 3 min. The gel 
was then incubated with fixative for 30 minutes followed by staining in colloidal 
Coomassie® G250 staining solution (section 2.2.3.2) overnight at RT. Next day 
staining solution was decanted off and gel was destained for 2 hr or more till until 
the gel matrix was almost destained and only specific protein bands were visible in 
minimal background. 
 
3.16.3 MS compatible silver staining: All solutions were made fresh and using 
high purity chemical in Milli-Q™ H2O. After completion of electrophoresis the 
part of the gel to be silver stained was cut out from the glass plates and washed in 
dH2O for 3 min. Thereafter the gel was incubated overnight at 4ºC in the fixative 
(section 2.2.4). Next morning gel was washed in 30% EtOH twice for 20 min each. 
The gel was then washed in Milli-Q™ H2O for 20 min. The gel was then sensitized 
for 1 min followed by washing three times in Milli-Q™ H2O for 20 seconds each. 
The gel was then incubated in prechilled, AgNO3 solution at 4ºC for 20 mins. The 
gel was again washed three times in Milli-Q™ H2O for 20 seconds each. The gel 
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was transferred in a fresh container and rewashed in Milli-Q™ H2O for 1 min. A 
small volume of developer was then added to the gel to remove excess stain from 
the gel and the coloured developer was discarded. More developer was then added 
to develop the bands until suitable intensity was observed. The reaction was 
stopped by discarding the developer and adding stopping solution. Finally the gel 
was washed briefly in Milli-Q™ H2O and preserved in 1% acetic acid at 4ºC. 
3.16.4  Destaining silver stained gels: For destaining of silver stained gels, the gel 
was incubated in the freshly prepared destaining solution (section 2.2.5) with mild 
shaking at RT. A mini-gel is destained in about 15 min. Destaining was stopped by 
adding the stopping solution. The gel could now be preserved in the storage 
solution or washed three times in Milli-Q™ H2O for 10 min each, after which it is 
like a fixed gel, ready to be restained with silver (beginning from sensitization 
step) or Coomassie (beginning from staining step). Staining gels for the second 
time after destaining apparently gives better staining probably because of removal 
of some of the impurities. 
3.17 Cryosections and immunostaining: Cryosection of adult fly heads were 
made as previously described (Buchner et al., 1986). In brief, adult flies were 
anesthetized and immersed in freshly prepared, ice-cold fixative (section 2.2.14). 
Their proboscis and ventral air sacs in the head were removed under a 
stereomicroscope, followed by fixation for 3 hr at 4ºC. Thereafter flies were 
washed once in cryoprotectant solution and incubated in the cryoprotectant 
overnight at 4ºC. The desired body part (head or whole body) was then embedded 
in a drop of the embedding medium (section 2.2.14) which was placed on a metal 
holder and the specimen was oriented for horizontal sections. The holder with the 
preparation was immersed in melting nitrogen (slush, obtained by evacuation of 
liquid nitrogen in a desiccator) for rapid freezing to reduce tissue damage by ice 
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crystal formation. Thereafter 10 µm thick cryosections were cut at -26ºC with a 
cryotome (2800 Frigocut® E, Reichert Jung). Series of consecutive 10 µm sections 
were collected on subbed glass slides (Menzel Gläser), thawed on the slide and air-
dried. The slides were blocked for 2 hr at RT in a humid chamber with normal 
serum (1:66 in 1x PBST pH 7.6) from the species in which the secondary antibody 
was generated (Vectastain®, Vector Labs). Thereafter the sections were incubated 
with 1° Ab suitably diluted in 1x PBST at 4ºC overnight in a humid chamber. Next 
morning slides were brought back to RT for 30 min and excess 1° mAb was 
drained off, the slides were washed once briefly and then twice for 10 min each 
with 1x PBST. The slides were incubated with biotinylated α-mouse IgG 
secondary Ab (diluted 1:200 in 1x PBST) at 37ºC for 1 hr and the signal was 
developed as Avidin-Biotin Complex (Mouse ABC Kit, Vector Labs) using 3,3’-
diaminobenzidine (DAB, Linaris) following the manufacturer’s instructions. After 
washing in PBS the sections were permanently mounted with Kaiser’s gelatin 
(Merck). The sections were imaged in transmission brightfield mode (Leica DMR). 
 
3.18  Collection of eggs: For collection of eggs, grape juice agar plates were 
made as described in section 2.2.13. Adult flies were anesthetized and collected 
over the solidified agar on plates. An empty fly vial with holes made in its bottom 
and having a vial stopper stuffed inside and pushed to the bottom was inverted and 
placed on the petri plate such that their mouths overlapped (as shown in Fig. 5 
above). The two were then sealed with cellotape and the flies were allowed to 
recover. The vials were incubated in 25ºC and flies were allowed to lay eggs on the 
agar surface. Plates were withdrawn after 8 hr and flies were anesthetized with CO2 
on the vial stopper and plates were carefully replaced with fresh plates. The eggs 
laid on the plates could now be scraped off gently with a wet brush for further 
experiments. 
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Fig. 5. Assembly of egg collection chamber. 
 
 
3.18.1 Selection of EPS-15 homozygous mutants: For screening EPS-15 mutants 
the embryos from the heterozygous eps15 mutant line (balanced over a CyO 
chromosome with a GFP marker) were observed under a stereomicroscope while 
being illuminated with blue light which was able to excite the GFP fluorescent 
emission. The heterozygous embryos were removed allowing only the GFP 
negative homozygous mutants to develop. Only few of the embryos developed to 
late 3rd instar larval stage and only a single one developed to become a male 
(though comparatively smaller in size). This fly’s head was later tested on the 
Western blot with respect to a CS fly head for absence of signal with the ab52 
antibody. 
3.19  Adult brain whole mounts: For preparation of adult brain whole mounts, 
adult flies were anesthetized with CO2 and collected over a glass petri plate and 
kept on ice to keep them immobile. An adult fly was placed onto a silica dish with 
its dorsal side down and fixed with a pin through its abdomen as shown below in 
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Fig. 6. The fly was bathed in prechilled Ringer solution as described in section 
2.2.14. The proboscis and ventral air sacs were removed under a stereomicroscope. 
The head capsule was dissected by pulling apart the eyes on either side to expose 
 
Fig. 6. Schematic of adult CNS dissection adapted from Ito, 1999. 
 
the brain. Fat bodies and tracheal tissues sticking to the brain were removed 
followed by fixation of the brain for 1 hr at RT. Thereafter fixed brains were 
washed three times in 1x PBST (section 2.2.15) for 10 min each at RT. Then brains 
were blocked for 2 hr in RT followed by overnight incubation with 1° Ab (suitably 
diluted in blocking solution) at 4°C. Next day brains were brought to RT for 30 
min before being washed 6 times in 1x PBST for 30 min each at RT. Thereafter 
brains were incubated overnight with corresponding 2° Ab (section 2.4.2) diluted 
suitably in blocking solution at 4°C. Next day brains were washed as earlier and 
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mounted on Vectashield™ (Vetor Labs) fluorescent mounting medium and stored in 
darkness at 4°C. 
 
3.20  Larval brain whole mounts: For preparation of larval brain whole mounts, 
freely moving 3rd instar larvae were collected using a brush and placed in pre-
chilled Ringer solution in glass petri plate and kept on ice to keep them immobile. 
Thereafter a larva was placed on silica dish under a stereomicroscope and was 
pinched with 2 forceps at a position around 1/3rd of its body length from the 
anterior tip. The body is then gently ripped open by pulling the forceps apart as 
shown in the schematic below. The anterior part of the body was slowly opened up 
and surrounding tissues were removed. Thereafter the cleaned brains were fixed 
(recipe described in section 2.2.16) for 30 min at RT. Thereafter fixed brains were 
washes thrice in 1x PBST for 10 min each at RT. Then fixed brains were blocked 
for 90 min in RT followed by overnight incubation with 1° Ab (suitably diluted in 
blocking solution) at 4°C. Next day brains were brought to RT for 30 min before 
being washed 6 times in 1x PBST for 30 min each at RT. Thereafter brains were 
incubated overnight with corresponding 2° Ab (section 2.4.2) diluted suitably in 
blocking solution at 4°C. Next day brains were washed as earlier and mounted on 
Vectashield™ (Vetor Labs) fluorescent mounting medium and stored in darkness at 
4°C. Both adult and larval brains were imaged as soon as possible using a confocal 
laser scanning microscope (SP2, Leica). The confocal stacks were analyzed and 3D 
 
Fig. 7. Schematic of adult CNS dissection adapted from Ito, 1999. 
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reconstructions were generated using the Fiji (Schindelin, 2008; Schmid et al., 
2010) based on ImageJ (Collins, 2007). 
 
3.21  Purification of IgM by CHA column chromatography: Low and high salt 
buffers (section 2.2.19) were made as per the Henderson-Hasselbalch equation 
(Henderson, 1908; Hasselbalch, 1917). Buffers were filter sterilized (0.45 µm, 
Millipore) and degassed before use. 40 ml of serum-free cell culture supernatant 
was equilibrated to room temperature by gentle mixing on the rotary shaker and 
then clarified through a 0.2µ filter (Whatman). A 5ml ceramic hydroxyapatite 
column (Bio-Scale Mini™ CHT Type II 40µm, Bio-Rad) was used with a Äkta 
Purifier (GE Healthcare) FPLC system for the purification. The column was first 
rinsed with 10 column volumes of the high salt buffer at a flow rate of 1ml/min to 
wash out all bound substances, followed by equilibration with 10 column volumes 
of the low salt buffer at 1 ml/min. Thereafter sample was loaded onto the column 
at 0.2 ml/min. The flow through was collected and then the column was washed 
with 100ml of the low salt buffer at 0.5 ml/min. Finally the IgM was eluted using a 
linear gradient from 10mM to 500mM over a volume of 40 ml at 1ml/min. 0.4 ml 
eluate fractions were collected and resolved by SDS-PAGE as described in section 
3.10.2 and blotted on nitrocellulose membrane as described in section 3.11. The 
blots were stained with Ponceau S to estimate the protein content and developed 
with anti-IgM antibodies (section 2.4) to check for the elution profile of the IgM. 
The purified IgM from specific fractions were also used to detect the target antigen 
in Western blot of wild type fly head homogenates and cryosections of fly heads. 
 
3.22  Partial enrichment of the na21 antigen by ion exchange 
chromatography: Partial enrichment of the endogenously expressed na21 antigen 
from head homogenates was tried using ion exchange chromatography. Total 
membrane pellet P2 was resuspended in 0.4% CHAPS followed by 
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ultracentrifugation at 100000g for 1 hr at 4°C. The supernatant was then diluted by 
7.5 volumes to reduce the detergent concentration well below its CMC (thus to 
prevent the formation of micelles) using 4 M Urea as a chaotrope. The sample was 
then dialyzed overnight against the homogenization buffer (section 2.2.9) 
supplemented with 4 M Urea through a cellulose membrane (ZelluTrans, Carl 
Roth) with MWCO 4000-6000. Next morning the dialyzed sample was again 
centrifuged as above and the clarified supernatant was loaded onto a Mono Q™ 
(GE) column which was already washed and equilibrated with the low salt buffer 
A (section 2.2.20). Proteins were eluted with a linear gradient of the high salt 
buffer B. Fractions were precipitated with TCA and tested on Western blots. 
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Chapter 4.  RESULTS AND DISCUSSION 
This doctoral project involved identification and characterization of antigens 
recognized by monoclonal antibodies from the Wuerzburg Hybridoma Library 
(Hofbauer 1991; Hofbauer et al., 2009). The monoclonal antibodies that gave a 
clear signal on Western blots and hence could be characterized not only based on 
anatomical stainings but also in terms of their biochemical properties were ab52 
and na21. Some other monoclonal antibodies were also studied but they failed to 
give a clear signal on Western blots. Hence these monoclonal antibodies could be 
only studied by immunohistochemistry to describe their staining pattern and thus to 
illustrate the localization of their target antigens. This section is therefore divided 
into three major parts: ab52 (4.1), na21 (4.2) and other mAbs (4.3). 
4.1 Monoclonal antibody ab52 (Halder et al., 2011): 
Migration pattern of antigen recognized by ab52 on 1DE: 
The monoclonal antibody ab52 recognized a single distinct band around ~100 kDa 
on Western blots of freshly homogenized, wild-type (Canton S) fly heads as shown 
in Fig. 9a. The monoclonal gave a clear signal at dilution 1:10 with a single fly 
head loaded per lane.  
Staining pattern of the mAbs ab52 on cryosections: Immunohistochemical 
studies based on staining of cryosections of adult fly heads showed ubiquitous 
staining of the synaptic neuropil. The central brain, optic lobe and all other 
neuropils were strongly stained, indicating that the antigen is expressed throughout 
the brain and localized in the synaptic neuropils as shown in the Fig. 9c. 
Characterization of the mAb isotype: Upon isotyping, ab52 was found to be an 
IgM with a kappa (κ) type light chain. In general IgMs, are unsuitable for 
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enrichment of their target antigens by immunoprecipitation (IP). However IP was 
nonetheless pursued with mAb ab52, but as expected, it was not successful. This 
could also be partly due to the low antibody concentration of the antibody in the 
supernatant, evident from the fact that a clear Western blot signal is achieved only 
when the supernatant is used at dilution 1:10 or less.  
Subcellular fractionation of the ab52 antigen: To find out more about the 
antigen, subcellular fractions from fly head homogenate were generated by 
utracentrifugation at 100000 x g (as described in section 3.9). When tested on 
Western blots, (Fig. 9b) a signal for ab52 was obtained exclusively in the cytosolic 
supernatant (S2) indicating that the antigen is soluble under the conditions of 
homogenization. CSP, a protein attached to the synaptic vesicles by a palmitoyl 
membrane anchor (Gundersen et al., 1994) is recognized by ab49 only in the total 
membrane pellet P2. Hence ab49 can be used as the membrane marker, thus 
demonstrating the effectiveness of the fractionation. 
a  b  c 	  
 
Fig. 9. (a) Western blot of a single Canton S fly head showing a single band recognized by ab52. 
(b) Western blot of subcellular fractions of wild-type (CS) fly heads showing that the protein 
detected by mAb ab52 is exclusively present in the cytosolic supernatant. S1 = postnuclear 
supernatant; S2 = cytosolic fraction; P2 = total membrane fraction (10 head equivalents loaded 
per lane). The synaptic vesicle protein CSP recognized by the mAb ab49 was used as the marker 
for the total membrane fraction. (c) Cyrosection of adult fly head showing ubiquitous staining 
pattern with mAb ab52 (dilution 1:5) in the optic neuropil. E = eye; L = lamina; MC=medulla 
cell bodies; M = medulla; Lo = lobula and Lp = lobula plate. 
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Migration pattern of antigen recognized by ab52 on 2DE: Conventional one 
dimensional SDS-PAGE (1DE) was not suitable to purify the antigen sufficiently 
to identify it. However, the soluble nature of the antigen allowed us to resolve it as 
a distinct spot by two dimensional electrophoresis (2DE). The Zoom® 2D setup 
(Invitrogen) was used as described in section 3.13.4. Proteins resolved in the gel 
were blotted as described in section 3.14. The blot was incubated with the 
monoclonal ab52 (dilution 1:10). Monoclonal antibodies 3C11 (dilution 1:100) 
which recognizes Synapsins and nc46 (dilution 1:200) which recognizes SAP-47 
respectively, were used as positive controls. The antigen recognized by ab52 was 
detected on the blot as a single distinct spot around the size expected from one 
dimensional SDS-PAGE at a pI around 6 as shown in Fig. 10. 
When the same gel after blotting was stained with silver, it was however not 
possible to detect a spot corresponding to the signal on the Western blot, probably 
due to the fact that very little amount of protein remained in the gel after the blot. 
Also only a small amount of protein (50 µg) can be loaded on the small-sized IPG  
 
Fig. 10. Western blot of fly head proteins resolved by 2DE (IEF/SDS), showing the antigen 
recognized by ab52 as a distinct spot around pI 6. Synapsins recognized by 3C11 and SAP-47 
recognized by nc46 were used as positive controls. Synapsins were seen as a group of ~22 spots. 
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strips in order to obtain optimal resolution. Hence the ab52 antigen could possibly 
load higher amounts of proteins (see below). It was also found that Synapsin was 
be resolved as a single, distinct spot by using largersized 2DE gels with capacity to 
not only resolved into the three major bands along the vertical axis (due to their 
Mr) between 70-90 kDa, as seen in 1D blots (Klagges et al., 1996) but each band 
was further resolved along the horizontal axis as an array of spots extending 
towards the acidic side of the pH gradient. The spots differed in their pI values and 
hence were probably post-translationally modified versions of Synapsins for each 
band (cf. Disussion).  
 
Enrichment of the antigen of mAb ab52 by 2DE (NEPHGE/ SDS-PAGE): The 
observation that the antigen recognized by the mAb ab52, can be resolved by 2DE 
as a single, distinct spot, was followed up by using larger sized 2DE gels to allow 
loading of more sample. For better resolution of proteins, NEPHGE was performed  
 
Fig. 11. (A) Signals from Western blot after 2hr exposure. The signal from the monoclonal 
antibody ab52 can be clearly seen as distinct a spot ~100kDa, with a corresponding strong signal 
in the 1D lane, which was loaded with 10 freshly homogenized fly heads. Non-specific signals 
were numbered as landmarks 1’- 6’. (B) Silver stained NEPHGE gel with protein spots 
corresponding to the non-specific Western signals numbered 1 - 6 and the spot corresponding to 
the Western signal from the monoclonal antibody ab52 (encircled in red). 
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after O’Farrell et al., (1977). Proteins from the cytosolic fraction (S2) were 
precipitated with 9 volumes of chilled acetone for 3 hr at -20°C, redissolved in the 
lysis buffers 1 and 2 and resolved as per their pI in tube gels by NEPHGE (section 
3.13.5), followed by SDS-PAGE. The separated proteins were blotted for only 20 
min, to transfer only part of the protein content onto the membrane, while retaining 
the rest of it in the gel. The proteins in the gel were visualized by MS-compatible 
silver staining (Fig. 11B). The blot was then incubated with mAb ab52 (1:10) and 
developed with a long exposure of 2 hours to obtain, besides the specific signal for 
the ab52 antigen, some non-specific spots (Fig. 11A) as landmarks relative to the 
specific signal. The non-specific spots on the Western blot were numbered 1’- 6’ 
and their corresponding spots on the gel were numbered 1- 6. Images of the silver 
stained gel and blot were digitally superimposed to align the pairs of spots and thus 
pinpoint the silver-stained spot (encircled in Fig. 11B), corresponding to the mAb 
ab52 antigen signal in the Western blot. The spot was excised and analyzed by 
mass spectrometry (by Dr. Urs Lewandrowski in the Sickmann group at the Rudolf 
Virchow Center of the University of Wuerzburg). 
 
Mass spectrometric identification of the antigen candidates: The protein spot 
excised out of the NEPHGE 2D gel (encircled in Fig. 11B) was analyzed by MS as 
described earlier (Hofbauer et al., 2009) and was found to contain peptide patterns  
 
Accession Protein MW Cumulative 
Mascot 
scoring 
Sequence 
coverage 
Q8MMD3 Epidermal growth factor 
receptor pathway substrate clone 
15* 
119761 1039 35 
Q9VUC1  Hsc70Cb* 89016 483 13 
P16568 Protein Bicaudal D 89127 115 3 
Table 7. Proteins identified in the gel piece encircled in Fig. 11B. *These protein identifications 
featured several different accession entries which belonged to the same protein but isoforms 
were not resolvable. Accessions are given in Swiss-Prot format. 
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that could be matched only to three proteins of the Drosophila proteome (Table 7). 
Since Hsc70Cb and Bicaudal D have not been reported to localize to the synaptic 
neuropil or the peri-active zone where the mAb ab52 antigen is detected, these 
proteins presumably are false positive hits leaving EPS-15 as a strong candidate. 
 
aa2 also recognized EPS-15, comparison of migration pattern aa2 and ab52 
antigens on 1DE: Interestingly another mAb from the Wuerzburg Hybridoma 
Library, namely aa2 was already shown to recognize the antigen EPS-15 (Chen, 
2009; Hofbauer et al., 2009). To check whether the antigens recognized by aa2 and 
ab52 display identical properties, proteins from freshly homogenized, CS fly heads 
were resolved by 1D SDS-PAGE, followed by Western blotting. The blot of a 
single lane was vertically cut into two halves. One half of the lane was incubated 
with mAb aa2 and the other with mAb ab52 (Fig. 12) and both were developed 
together. The developed blots suggest that the antigens recognized by the two 
antibodies have the same electrophoretic mobility and hence maybe the same 
protein, EPS-15. 
 
Fig. 12. Blot of a single SDS gel electrophoresis lane loaded with homogenate from 2 wild-type 
(CS) heads. The blotted membrane was vertically cut in two halves; one was developed with 
mAb aa2 (left), the other with mAb52 (right). The signals at identical Mr suggests that both 
mAbs probably recognize the same antigen. 
 
 
Migration pattern of the antigens recognized by aa2 and ab52 on 2DE: Since 
aa2 and ab52 seemed to recognize the same antigen on 1DE and since the antigen 
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recognized by ab52 was found to be a soluble, cytosolic protein, we repeated 2DE 
experiment to compare the Western blots signals of the 2DE profile for both the 
mAbs aa2 and ab52. CS fly head homogenates were resolved by 2DE (IEF/SDS-
PAGE) followed by partial Western blot of the same gel, consecutively on two 
separate membranes to get duplicate blots of the same 2DE separation profile. 
Development of the blots incubated with aa2 and ab52 separately, revealed signals 
for both antibodies as a single, distinct spot with identical patterns having Mr ~100 
kD in the pI range 6-7 as shown in the Fig. 13. This further indicated that both the 
mAbs indeed may recognize the same antigen. 
 
 
Fig. 13. Two sequential Western blots from a single 2DE gel loaded with sample equivalent to 
25 fly heads. The two membranes were cut along the horizontal white line, the upper parts were 
developed with mAbs ab52 (left, dilution 1:10) or aa2 (right, dilution 1:2), the lower parts were 
stained with mAbs 3C11 (anti-SYN, 1:100) and nc46 (anti-SAP47, 1:200) as controls for both 
blots. 
 
Staining pattern of the mAbs aa2 and ab52: On cryosections of adult heads 
these two antibodies equally stain all synaptic neuropil as shown for aa2 in Fig. 
14A. Immunohistochemical experiments of larval NMJ preparations also showed 
similar staining patterns for both ab52 and aa2 (Fig. 14B and 14C). To finally 
prove that ab52 recognizes EPS-15, we tested homozygous Eps15 null mutant 
escapers on Western blot with ab52. The Eps15 mutant fly stock kindly provided 
by Hugo Bellen had the following genotype:                           
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                                         yw ;     eps15Δ29       ;   +  
                                                 CyO, twi>GFP    + 
 
Flies were allowed to lay eggs on grape-juice-agar plates (section 3.18) and then 
homozygous Eps15 mutant embryos were retained by selecting the GFP negative 
 
 
Fig. 14. (A) Cryosections of an adult fly head were probed with mAb aa2 (left) and mAb ab52 
(right). Both antibodies stain all synaptic neuropil (green) but not the surrounding the cell body 
layer whose nuclei are stained with DAPI (blue). (B, C) Synaptic boutons of larval motor neuron 
terminals stained with anti-HRP (left, red) and mAbs aa2 (B, middle, green), or ab52 (C, middle, 
green). The overlays in the right column demonstrate that the epitopes recognized by both mAbs 
are present in all boutons (here shown for muscles M12/13 (B) and muscles M6/7 (C)) but not in 
the axons. Scale bars in A: 100 µm; in C for B and C: 50 µm) 
 
ones lacking the the GFP-labeled CyO chromosome. Out of the few selected 
embryos only a single one survived to become a small sized, adult male. This adult 
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“escaper” was tested again for its genotype by checking for absence of the GFP 
signal under a fluorescence microscope in comparison to the heterozygous mutant 
stock as shown in Fig. 15. When this individual fly’s head homogenate was tested 
on Western blot, it gave no signal with the mAb ab52, while SAP47 used as a 
loading control was present in both (Fig. 16), along with faint non-specific, 
background signals. This demonstrated beyond any reasonable doubt that mAb 
ab52 recognizes the protein EPS-15 of Drosophila. 
 
Fig. 15. Balanced fly head as viewed under bright-field transmission mode (a) and fluorescence 
mode (b) showing GFP expression from the balancer CyO chromosome. Homozygous escaper 
fly head as viewed under bright-field transmission mode (c) and fluorescence mode (d) showing 
lack of any GFP expression. 
 
Fig. 16. Western Blot with mAb ab52 showing the absence of the wild type signal in the Eps15 
null mutant. SAP-47 recognized by mAb nc46 was used as the loading control. 
 
This was further confirmed by immunostainings of the larval CNS of the 
homozygous null mutant escapers (Fig. 17A-B). The staining pattern of the guinea 
pig anti-Eps15 (red) antiserum (kindly provide by H.  Bellen) (1:300) in 1x PBST 
perfectly matches (yellow) that of aa2 (green) in synaptic boutons on muscle M13 
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(Fig. 17C). 
 
Fig 17. Immunohistochemical staining of larval synaptic neuropil with mAbs aa2 (A) and ab52 
(B) is present in wild type (WT) but absent in eps15Δ29 null mutants (Δ29) and perfectly matches 
the distribution of Eps15 in synaptic boutons, here shown on muscle M13 (C). Scale bar in A for 
A and B: 100 µm; in C: 5 µm. 
 
4.1.1 Disscussion 
We conclude that the two of the mAbs of the Würzburg Hybridoma Library: aa2 
and ab52 recognize the same protein, Eps15 of Drosophila. As the two mAbs are 
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of different isotypes, they apparently are produced by two distinct hybridoma cell 
lines and can not be sublcones from a common parent cell. aa2 being an IgG1 is 
more suitable for applications like IP and hence has already been contributed to the 
Developmental Studies Hybridoma Bank (DSHB) or easy distribution to the entire 
research community.  However ab52 being an IgM is only suitable for 
immunostainings and Western blots. 
EPS-15 in Drosophila has been characterized as a protein of the peri-active zone 
required for normal synaptic bouton development and synaptic vesicle recycling 
(Majumdar et al., 2006; Koh et al., 2007). 
An interesting by-product of the 2DE analysis of the ab52 antigen was the 
observation of the conspicuous train of synapsin isoforms (Fig. 10).  
Protein isoforms differing by a single charge yield such a ‘train of spots’ on 2DE 
(Anderson and Hickman, 1979). Hence 2DE is able to resolve proteins with even 
single charge differences and thus can demonstrate minute differential post-
translational modifications in isoforms of a given protein that lead to differences in 
their pI values. Phosophorylation is one such post-translational modification 
known to lower the pI of proteins, often seen as a shift of the spots by 1 to 2 pH 
units per phosphoryl group added, towards the acidic end of the pH gradient 
(Yamagata et al., 2002). The observed shift is due to the very low pK value of the 
PO4 group and its repulsive interactions to SDS, reducing the number of SDS 
molecules that can bind to the protein (Immler et al., 1998). Since every additional 
phosphorylation on a protein will cause a further shift, an increasing number of 
phosphorylations would thus lead to ‘train of spots’ (Görg et al., 2004).  Since 
vertebrate Synapsins are known to have multiple phosphorylation sites (Cesca et 
al., 2010), its differentially phosphorylated forms can lead to such trains of spots 
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horizontally shifted towards the acidic end in 2DE (Kang et al., 2010). Fig 10 may 
have been the first demonstration of the existence of multiple phosphorylated 
forms of Drosophila Synapsins seen by the ‘train of spots’ in a 2D gel. It was 
however not possible to get well stained spots in a stained gel, corresponding to 
such train of spots on a blot, probably due to the low protein loading capacity of 
the small sized 2D gels. This observation was however reproducible (Racic, 2010). 
Recently immunoprecipitation of Drosophila Synapsins using the mAb 3C11, 
followed by separation of major isoforms by 1D SDS-PAGE and mass 
spectrometric analysis of the 1D bands showed the presence of multiple 
phosphorylations in Synapsins (Nuwal et al., 2011). It is also noteworthy that an 
additional, heavier band for Synapsin was observed) in Sap47 null mutant 
(Sap47156) flies which was not observed in samples treated with alkaline 
phosphatase (N. Funk unpublished; Nuwal, 2010). This could be a hint for a 
possible interaction of the two proteins SAP-47 and Synapsins, in a 
phosphorylation dependent manner. Also Sap47156 mutant larvae were recently 
shown to have a 50% reduction in odorant-tastant associative learning ability 
(Saumweber et al., 2011). Synapsins are assumed to tether the synaptic vesicles to 
the cytomatrix of the presynaptic terminal and phosphorylation is believed to play 
a role in the recruitment of vesicles to the various vesicle pools (Fdez and Hilfiker, 
2006). The demonstration of hyperphosphorylated Drosophila Synapsins, calls for 
a detailed study of the various phosphorylated forms of Synapsins and their 
possible role in synaptic vesicle recruitment, learning and memory. Around 22 
spots of synapsins were observed in the blot above and 2D-PAGE using larger gels 
with higher protein loading capacity and greater resolution ability could probably 
lead to an increase in the number of distinct spots. Hence 2DE would probably be 
the best-suited technique for further study of the various phosphorylated forms of 
Synapsins. 
	  	   69	  
 
4.2 Monoclonal antibody na21: 
Migration pattern of antigen recognized by na21 on 1DE: 
The monoclonal antibody na21 recognized a single antigen as a distinct band at Mr 
~9 kDa on Western blots of freshly homogenized, CS fly heads as shown below, in 
Fig. 18a. The monoclonal gave a signal at dilution 1:10 with a single fly head 
loaded per lane. Besides the head, the antigen was also detected in other body parts 
like: thorax, abdomen in both genders, with high abundance in female abdomen 
(due to its presence in oocytes as shown later). The antigen was found to be present 
in all life stages right from embryo to adulthood (Fig. 18b).  
To check whether the protein is conserved, various species of fruitflies were also 
tested on Western blots and a distinct band at ~9 kD was found in all of them as 
well (Fig. 18c). 
 
Fig. 18. (a) Western blot of 1 freshly homogenized CS fly head loaded, showing a single distinct 
signal for the mAb na21 (1:10). (b) Western blot of different life stages and body parts, showing 
presence of the na21 antigen in the various samples. (c) Western blot of various fruitfly species 
showing the na21 antigen to be conserved in all, like the loading control SAP-47. sim = D. 
simulans, ana = D. ananassae, will = D. willistoni, sec = D. sechellia, yak =  D. yakuba. 
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Staining pattern of the mAbs na21: On cryosections of adult heads, na21 gave a 
highly specific and interesting staining pattern. It stains all synaptic neuropil in the 
brain (Fig. 19a), with particularly strong signals in specific layers within the optic 
lobe, like layers 1, 4/5 and 10 of the medulla, layer 1 and 2 of the lobula 
(Fischbach and Dittrich, 1989) and slightly fainter signal in the lobula plate as 
shown below in Fig. 19b. It is noteworthy that one of the optic neuropils, the 
lamina is not stained at all. Because a signal of similar Mr was detected in Western 
blot of various species of fruit flies by na21 and the mAb also gave a faint signal in  
 
Fig. 19. (a) Cryosection of an adult head stained with na21 (1:3) and DAB showing strong 
labeling of all central brain neuropils and specific synaptic layers in the optic neuropil. (b) 
Staining of the same synaptic layers of the optic neuropil reproduced with fluorescent secondary 
antibody. (c) A cryosection of honey bee brain stained with na21 also showing a similar staining 
pattern. SOG =sub-oesophageal ganglion, L = lamina, M = medulla, Lo = Lobula, Lp = lobula 
plate, CB = central brain. 
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Western blot of honeybee brain, we checked for the staining pattern in honeybee 
brain cryosections (Fig. 19c). 
         
Fig. 20. Whole body cryosections, stained by na21 showing staining in sensory cells of the 
antennae (a) and specific synapses of the indirect flight muscle in the thorax (b). 
 
na21 showed a similar staining pattern with strong staining of the most proximal 
layer of the medulla and first layer of the lobula (there is no lobula plate in the 
honey bee brain). Besides the brain neuropils, na21 also stains sensory cells in the 
antennae in adult fly head cryosections as shown in Fig. 20a. Following up with 
the Western blot showing presence of the antigen in other body parts, whole body 
cryosections were also made and stained with na21. It was found to stain specific 
synapses in the indirect flight muscles in the thorax as shown in Fig. 20b. The 
thoracic ganglion was also strongly stained (Fig. 21a), corresponding to the mAb’s 
strong staining of the central brain neuropils. A pair of organs at the tip of the 
female abdomen, were also stained (Fig. 21b), which probably are the muscles for 
   
Fig. 21. (a) Cryosection of the thoracic ganglion showing strong staining of the synaptic neuropil 
(b) A pair of organs at the tip of the female abdomen was also stained strongly by the antibody. 
	  	   72	  
copulation and egg laying. Cryosection of female abdomen also revealed 
conspicuous na21 staining in the oocytes. The mAb strongly stained the posterior 
apical cell in each oogonia, which is the egg cell indicating abundant expression of 
the antigen in egg cell, while the adjacent nurse cells were devoid of staining as 
shown below in Fig. 22. The strong signal from eggs was also confirmed on blots 
 
 
 
Fig. 22. Different sections of female abdomen with strong staining for the apical egg cell in 
oogonia with DAB (a-e) and fluorescence staining (f, g). E = egg cell, N = nurse cells, O = 
oogonium, T = tegument. (h) Western blot of 20 embryos compared to one adult head. 
 
 
 
Fig. 23. Cryosection of embryo showing punctate staining with na21. 
 
as shown below in Fig. 22h. Furthermore, cryosections of early embryos when 
stained with na21 also showed punctate staining as shown below in Fig. 23. 
Immunostainings of adult brain whole mounts also stained the specific synaptic 
layers (Fig. 24) as seen earlier in cryosections, thus confirming the specific 
staining pattern of na21. Staining of larval brain whole mounts and NMJs did not 
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show any strong staining that could be interpreted (Fig. 25). 
 
 
 
Fig. 24. (a) Confocal slice imaged in the horizontal plane showing a staining pattern similar to 
Fig 18b. (b) A slice imaged in the frontal plane showing the specific layers in the medulla and 
lobula. 
 
  
Fig. 25. na21 staining layer around neurolemma in larval motor neurons. 
 
Fig. 26. ELISA plate showing stronger signals for IgM (5th column) for 3 different aliquots of 
na21 (duplicate rows A-B, E-F and G-H), while mAb 3C11 (anti-SYN) which is known to be an 
IgG2b was used as a positive control (duplicate row C-D). 
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Characterization of the mAb isotype: Upon isotyping with capture ELISA and 
immunoreactive strips (section 3.6), na21 was found to be an IgM with kappa (κ) 
type light chain (Fig. 26). 
Biochemical properties of the na21 antigen: To find out more about the 
antigen’s properties, biochemical studies were carried out. Its subcellular 
localization, conditions for optimal solubility etc., were studied. 
 
Sub-cellular fractionation of the na21 antigen: Upon sub-cellular fractionation 
(section 3.9), the protein was found to exclusively remain in the pellet which 
represents the total membrane fraction (Fig. 27). To determine if it the na21 
antigen could be a synaptic vesicle protein, the post-nuclear supernatant (S1) was 
resolved by (isopycnic) equilibrium density gradient centrifugation. 5-25% sucrose 
gradient was used as described in	   section 3.10. 9 fractions of 1 ml each were 
precipitated by TCA and analyzed by SDS-PAGE. A Western blot (Fig. 28) 
showed, that while cytosolic and peripherally attached proteins like Synapsins and  
 
 
Fig. 27. Subcellular fractionation of the na21 antigen. S1 = post-nuclear supernatant, S2 = 
cytosolic supernatant, P2 = total membrane pellet. HSP70 was used as a cytosolic marker, while 
Syntaxin was used as a membrane marker. 
 
SAP-47 stayed on top of the gradient, the synaptic vesicle protein CSP could enter 
the gradient and had a peak around fractions 3-5. The na21 antigen also had a 
similar distribution indicating that it could be a vesicle associated protein. To 
further confirm its integral membrane and vesicle associated nature, the membrane 
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Fig. 28. Western blot showing na21 antigen to be distributed similar to CSP along the sucrose 
gradient. 
 
(mostly integral) proteome was partially enriched by generation of 
proteoliposomes (section 3.11), in collaboration with Reinhard Jahn at the Max 
Planck Institute for Biophysical Chemistry in Göttingen. To first check for the 
possibility of formation of proteoliposomes, the total membrane pellet was 
dissolved by 1% (w/v) CHAPS, followed by ultracentrifugation to see if the na21 
antigen is solubilized into the supernatant (S3). S3 was then diluted 10 times to 
bring the CHAPS concentration to 0.1% (w/v) which is below its critical micelle 
concentration (CMC) such that the micelles would be disrupted while the 
formation of proteoliposomes should be facilitated. Any proteoliposome formed 
were pelleted as P4. Western blot showed that the antigen was not found to be in 
the pellet but remained in the supernatant S4 (data not shown) apparently because 
the proteoliposomes were not properly formed under these conditions since most of 
the Synaptobrevin (control protein) was also found in the S4. So we attempted to 
generate proteoliposomes once again (section 3.11.2). The 9 fractions eluted 
around the Rhodamine-PE peak were TCA precipitated and tested on Western 
blots. It was found that the na21 antigen was dissolved from the total membrane 
pellet (P2) by the 3% CHAPS like Synaptobrevin, as shown in Fig. 29a. The 
dissolved antigen was used to form the proteoliposomes with Soybean 
phospholipids and resolved through the gel filtration column. The elution profile of 
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Fig. 29. (a) The na21 antigen was dissolved by 3% CHAPS from the P2 like Synaptobrevin. (b) 
The na21 antigen has a similar elution profile as Synaptobrevin. 
  
the antigen was similar to that of Synaptobrevin, as seen in their peaks in similar 
fractions (Fig. 29b). Mass spectrometric analysis (by the group of Henning Urlaub, 
MPI-BPC, Goettingen) of fractions 4 and 5 led to more than 91 hits. The list of hits 
generated when arranged as per Mr (using the software Scaffold, ver 3.0, Proteome  
 
 
 
Fig. 30. Screen shot showing hits from MS analysis arranged as per Mr by Scaffold. 
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Software, Inc.) showed 26 hits which were <= 11 kDa as shown in the screen shot 
in Fig. 30. Upon careful analysis of the hits based on size, putative localization, 
level of expression, etc a list of 8 probable candidates was made as shown in Table 
8. Interestingly most of these hits were ATPases, especially vacuolar ATPases 
which were putative proton pumps. Synaptic vesicles are also known to contain at 
least one V-ATPase (Takamori et al., 2006). 
 
No. Protein/ Gene Information available on Flybase Size (kDa) 
1 Oligomycin 
sensitivity-
conferring protein 
CG4307 
molecular function: hydrogen-exporting ATPase activity, 
phosphorylative mechanism, 
biological process: proton transport 
13.5 
2 Vacuolar H+ 
ATPase 14kD 
subunit CG8210 
-do- 14 
3 CG3321 -do- 9 
4 Vacuolar H+ 
ATPase G-subunit  
CG6213 
-do- 14 
5 CG4692 -do- 12 
6 IP04021p CG1268 molecular function: -do- 
biological process: ATP hydrolysis coupled proton 
transport; ATP synthesis coupled proton transport 
10 
7 RE19842p 
VhaM9.7-2 
CG7625 
molecular function: -do- 
biological process: ATP hydrolysis coupled proton 
transport; ATP synthesis coupled proton transport 
10 
8 CG12400 molecular function: NADH dehydrogenase activity; 
NADH dehydrogenase (ubiquinone) activity, 
biological process: mitochondrial electron transport, NADH 
to ubiquinone 
13 
 
Table 8. List of probably candidates based on size and expression pattern. 
 
Moreover similarities in the biochemical behaviour of the protein in comparison to 
other synaptical vesicle proteins like CSP and Synaptobrevin (VAMP2) also 
indicate that the protein can be a synaptic vesicle protein. Due to time limitations, 
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these candidates could not be individually tested. The candidates maybe tested by 
checking their corresponding deficiency and RNAi lines for lack and/or reduction 
of signal in Western blots in comparison to equal amount of wild-type heads 
loaded. Gradient loading of sample would be recommendable for facilitating ease 
in detecting half gene dosage in such cases. 
 
To study the membrane association of the protein, alkaline extraction of the pellet 
(Fujiki et al., 1982) was done using 100 mM Na2CO3 pH 10, which could not 
release the protein from the pellet. However, at a higher pH of 11.5 the protein was 
partially extracted, thus indicating it to be a protein strongly associated to the 
membrane. The zwitterionic detergent Triton X-114 was able to completely 
dissolve the protein (Fig. 31a). Finally upon cloud point precipitation (Bordier, 
1981) of the total membrane pellet (P2) with Triton X-114 the protein was 
partitioned exclusively into the detergent phase (Fig. 31b). 
 
Fig. 31. (a) Alkaline extraction of the membrane pellet (P2) with 100 mM Na2CO3 pH 10 (1), 
100 mM  Na2CO3 pH 11.5 (2) and 2% Triton-X 114 (3). (b) Dissolution of the membrane pellet 
(P2) with 2% Triton X-114 followed by cloud point precipitation. aq1 =  aqueous phase after 1st 
precipitation, aq2 =  aqueous phase after 2nd precipitation, det = detergent phase after 2nd 
precipitation. SAP-47, a protein peripherally associated to the membrane was used as loading 
control. 
 
To further find conditions for solubilization of the protein, various detergents were 
used to dissolve the antigen and then the suitable ones were tested for the lowest 
possible concentrations required to dissolve the antigen and keep it in solution 
(Fig. 32) while trying to remain below the CMC values of these detergents to avoid 
the formation of micelles, which are not suitable for downstream processes.  
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Fig. 32. Effectiveness of various detergents at low concentrations to dissolve na21 antigen. S1 = 
Supernatant after 1st round of spin at 13,000 rpm (Post Nuclear Supernatant), S2 = Supernatant 
after 2nd round of spin at 100,000x g (Soluble/Cytosolic fraction), P2 = Pellet after 2nd round of 
spin at 100,000x g (Membrane fraction). SAP-47 was used as a loading control. 
1 = TX-114 0.5% (v/v)         2 = TX-114 0.25% (v/v)         3 = TX-100 0.5% (v/v) 
4 = TX-100 0.25% (v/v)         5 = CHAPS 0.5% (w/v)        6 = CHAPS 0.25% (w/v) 
 
a b  
Fig. 33. (a) IP with na21 showing no enrichment of the antigen with respect to the input, while 
IP with the control mAb 3C11 shows successful enrichment of the antigen Synapsin. (b) Silver 
stained gel of the IP samples showing no major band, but multiple bands near the expected Mr. 
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Using the low detergent concentrations (0.25% TX-114, 0.25% TX-100 and 0.5% 
CHAPS) it was attempted to bring the antigen into solution and then pull down the  
protein by immunoprecipitations using protein-G beads. These experiments did not 
succeed in enriching the antigen with respect to the input as shown in Fig. 33a. 
Besides the poor binding of protein-G to IgMs, presence of detergents may also 
prevent the binding of the Ab to the antigen. When samples from such IPs that did 
show a signal for the antigen in Western blots, were silver stained, the presence of 
many bands in the same size range as the na21 antigen made it impossible to 
pinpoint the exact band corresponding to the IP signal (Fig. 33b). 
 
Protein-L reported to bind to murine IgMs if they have the kappa-I (κ-I) type of 
light chains (Nilson et al. 1993). Since a method or kit for rapid determination of 
the light chain type of an Ab is not available, it was decided to purify the mAb 
from serum free supernatant to use it for an IP by covalent coupling to protein-L. If 
the mAb would be of the κ-I type, then it would bind to the protein-L beads and 
upon covalent coupling, we would have a bead-mAb complex ready for use in IP 
based immunoenrichment of the antigen. Hydroxyapatite based column 
chromatography was used as a simple, one-step method to purify the IgM from 
serum-free hybridoma culture supernatants (section 3.21). This work was done in 
collaboration with Clemens Grimm, at the department of Biochemistry, Biocenter, 
Uni Wuerzburg. As can be seen from the elution profile in Fig. 34A the mAb was 
eluted as a distinct peak (Peak 1) around 55% buffer B (320 mM sodium 
phosphate). A second peak was eluted (Peak 2) around 73% buffer B (392 mM 
sodium phosphate). The fractions were tested for the presence of the monoclonal 
antibody by Ponceau-S staining (Fig. 34B) and Western blot (Fig. 34C). Fractions 
30-35 corresponding to peak 1, gave strong signals for the mAb light and heavy 
chains in both Ponceau-S stainings and Westerns blots. The protein concentration 
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Fig. 34. (A) Elution profile of serum-free hybridoma supernatant applied to a CHT column using 
a linear sodium phosphate gradient. The A280 absorption is shown in blue, the salt gradient as 
fraction of buffer B in green. Peak 1 at 320 mM phosphate contained the IgM mAb, na21. (B) 
Ponceau-S stained blot showing protein profiles of serum-free (SF) and serum-supplemented 
(SS) supernatant as well as the eluted fractions. (C) Western blot of the same membrane. The 
used antibody mixture detects the heavy chain (HC), light chain (LC) and a band that can be 
ascribed to a heavy chain/light chain heterodimer (H+L). Fractions 30-35 correspond to peak 1, 
fractions 48-52 correspond to peak 2. 
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for fraction number 31 from the center of peak 1 was determined to be 0.14 mg/ml 
by BCA assay. Jugded from the Ponceau S stained blot (Fig 34B), peak 1 consists 
of approximately 90% pure mAb na21. Fractions 48-52, corresponding to peak 2, 
neither showed any protein bands on the Ponceau-S stained blot (Fig. 34B) nor 
gave any signals for mAb light or heavy chains in the Western blot (Fig. 34C). 
Protein concentration for fraction number 50, from the center of peak 2, was found 
to be 0.04 mg/ml. Therefore, peak 2 likely contained significant amounts of certain 
non-protein cell culture medium components with a high absorbance at 280nm. 
To test the functionality of the purified mAb, we resolved proteins from 2 freshly 
homogenized, CS fly heads per lane by SDS-PAGE, followed by blotting and 
detection of the target antigen with the purified mAB na21 in different lanes at 
dilutions 1:200, 1:500, 1:1000 and 1:2000, respectively. At a dilution of 1:2000, a 
faint signal was visible. A dilution of 1:1000 produced a satisfactory signal 
indicating a 100-fold activity increase per volume compared to crude supernatant, 
which yields a comparable signal only at a dilution of 1:10 (Fig 35). 
 
Fig. 35. Western blot of wildtype fly heads (2 heads per lane) showing the target antigen 
recognized by the unpurified supernatant at 1:10 dilution (lane 1) in comparison to the purified 
fraction C15 at a dilution 1:2000 (lane 2), 1:1000 (lane 3), 1:500 (lane 4), and 1:200 (lane 5), 
demonstrating that the eluted mAb was functional on Western blots at more than 100 fold higher 
dilution. SAP47 detected by mAb nc46 (1:200) was used as loading control. 
 
In immunohistochemical preparations of adult fly-head cryosections un-purified 
na21 supernatant (Fig. 36A) shows the characteristic staining pattern (cf. Fig. 19) 
at a dilution of 1:3, while the purified mAb stains with similar intensity at a 
dilution of 1:100 (Fig. 36B).  
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Fig 36. Frontal cryosections of adult fly heads immunostained with mAb na21 serum-free 
supernatant at dilution 1:3 (A) and purified fraction C15 at dilution 1:100 (B). The mAb in both 
cases stains most of the neuropil of the central brain (CB) seen here at the level of the esophageal 
canal. In the optic lobe neuropil na21 highlights specific layers in medulla (Me), and lobula (Lo) 
while the lamina (La), LP=lobula plate.  
 
Thus the mAb was purified to a high degree and eluted as a distinct peak. This 
purified mAb was then used in an attempt to immunoenrich the target antigen by 
covalent coupling to protein-L beads, but it was not able to pull down the antigen. 
In fact the failed elution of the Ab chains in the IP sample indicated that the IgM 
had not bound to the beads. This could be a hint that the IgM may not have the κ-I 
type of light chains. Hence mAb based immunopurification of the antigen did not 
seem to be the right approach to purify the antigen. 
 
So we tried to use Tricine SDS-PAGE (for better resolution of the proteins in the 
lower Mr range. Thereafter the proteins resolved on a 15% Tricine gel were 
partially blotted (i.e. for a shorter period of time so that most of the proteins still 
remained in the gel) and then the gel was stained with colloidal Commassie, while 
the membrane was developed to get a Western blot signal. By superimposing the 
images of the Western blot and the stained gel, the part of the gel corresponding to 
the Western signal which was then cut out and subjected to MS analysis to identify 
the protein (Fig. 37). The major candidate among the hits was the protein coded by 
the gene CG11051 called Neuropeptide like protein precursor-2 (Nplp2). But a 
deficiency line for the gene did not show any half-gene dosage effect when the 
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same amount of wild type and deficient samples were compared by a Western blot 
(data not shown). To definitely exclude Nplp-2 as the antigen for na21, the Nplp-2 
cDNA 
 
Fig. 37. Coomassie stained Tricine-SDS-PAGE gel with left half partially blotted and stained 
and right half directly stained, and used to compare the separation profile with the blot to 
pinpoint the region of the gel (red) corresponding to the Western blot signal. 
(RH08410) was obtained from the Drosophila Genomic Resource Center (DGRC, 
Indiana University, USA) as a pFLC plasmid, which was then double digested at 
the KpnI and NotI sites to get the full length cDNA out of the vector (Fig. 38a) 
followed by cloning into the pUAST vector. Success of cloning was cross-checked 
by double digestion of the vector to release the insert (Fig. 38b), which was 
confirmed by sequencing (MWG Operon). This pUAST vector was used for 
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generation of transgenic, UAS-Nplp-2 lines by P-element mediated germ-line 
transformation (Best Gene Inc.). Cryosections of flies with ectopic expression of 
the Nplp-2 transgene in the retina obtained by crossing the UAS-Nplp-2 lines with  
   
Fig. 38. (a) Double digestion of the pFLC vector with KpnI and NotI to get the full length cDNA 
insert. (b) Cloning of the insert into the pUAST vector followed by the double digestion to get 
the insert, which was checked by sequencing. 
the GMR-Gal4 driver line did not show any staining in the eyes with the mAb 
na21, though the normal staining of the synaptic neuropils was found (data not 
shown). As a result we could concluded that Nplp-2 was only a false hit and not 
antigen of mAb na21. 
In order to reduce the number of candidates prior to MS analysis biochemical 
purification of the antigen from homogenized heads was attempted in collaboration 
with Clemens Grimm, at the department of Biochemistry in the Biocenter at the 
University of Wuerzburg. Since the antigen was expressed endogenously and could 
not be overexpressed, a very large amount of starting material had to be used 
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keeping in mind the dramatic losses to be expected in various fractionation steps 
like centrifugations, chromatography etc. 
Total membrane pellet P2 (~ 30000 heads) was dissolved in 0.4% (w/v) CHAPS 
(below its CMC to avoid micelle formation), ultracentrifuged at 100000 g and the 
supernatant containing the protein was diluted to 7.5 volumes with 4 M Urea 
(which is a chaotrope and keeps membrane proteins in solution) followed by 
dialysis against 4 M Urea to further dilute the detergent to a negligible 
concentration. The dialyzed sample was then resolved through an anionic exchange 
column (MonoQ™, GE) and proteins were eluted using a 0.1 - 1 M salt gradient. 
The eluted fractions were TCA precipitated and tested on Western blots. The 
antigen was eluted as a peak over two fractions as shown in Fig. 39. CSP, being a 
relatively sticky protein also present in membrane was used as a positive control 
and was eluted in a broad range over all fractions but had a peak near the na21 
fractions. 
 
Fig. 39. Western blot of fractions eluted from anionic (MonoQ™) column showing the antigen 
eluted as a peak in two distinct fractions. CSP was used as a positive control. 
 
 
4.2.1 Discussion 
The signal around 9 kDa showed that the protein was a rather small one which 
could be around 87 amino acids. The antigen was present in all life stages and 
could be detected already in early embryos indicated that it was present as a 
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maternal protein and may also be expressed at a very early stage in development. 
This could indicate its possible role in development or a fundamental role in 
cellular system which requires its presence from such an early stage. The proteins 
presence in 5 other fruitfly species and a similar staining pattern of the mAb na21 
in honey bee brains also indicates towards the conserved nature of the protein, 
which is often an indication of the degree of necessity of a protein in the biological 
system.  
The ubiquitous staining of the central brain neuropils (which was continued via the 
sub-esophageal ganglion to the thoracic ganglion) but selectively stronger staining 
in the layers of the synaptic neuropils of the optic lobe, illustrates an interesting 
localization pattern for the protein. Hence it seems to be necessary in most central 
neuropils while being needed only in specific synapses of the optic neuropils. 
Similarly its presence in other body parts like sensory cells of the antennae, 
specific synapses of the indirect flight muscles, etc also indicated specialized role 
of the protein in various body parts. The 2nd and 3rd larval stages showed a second 
band in Western blots, which could be a splice variant of the gene (which would 
mean that the epitope is likely to be present in the common fragment). The 
presence of multiple isoforms also supports the possibility of differential 
localization due to differential splicing of the mRNA and possibly different roles 
of the isoforms in different tissues. 
Hence we could infer that the antigen is widely expressed in different body parts as 
indicated by the stainings. Though this was in agreement to the Western blot 
signals, but specificity of these staining could only be confirmed with absence of 
staining in a mutant for the antigen. This is however not possible until the target 
antigen recognized by na21 is identified. 
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The subcelular fractionation seemed to work well with the cytosolic marker HSP70 
and membrane marker Syntaxin being present exclusively in the supernatant and 
pellet fractions respectively. The partial extraction of the protein from the 
membrane pellet upon highly alkaline treatment indicated that the protein could be 
strongly associated to the membrane. Finally upon cloud point precipitation, the 
protein was partitioned exclusively into the detergent phase which indicating that it 
is probably an integral membrane protein. In the proteoliposome enrichment 
experiment, the elution profile of our protein of interest was similar to that of 
Synaptobrevin. This also indicated that the antigen behaves like an integral 
membrane protein and could be a vesicle associated protein. na21 was found to be 
an  IgM, so its application in IP for enrichment of its target antigen was unsuitable. 
IgMs are pentameric and show weak or no binding to protein-A, -G and A/G beads 
(Kronvall et al., 1974; Björck and Kronvall, 1984; Sikkema, 1989). However IP 
was still attempted but, as expected, it was not successful. This could also be due 
to the low antibody concentration of the antibody in the supernatant, evident from 
the fact that a strong Western blot signal is achieved only when the supernatant is 
used at dilution 1:10 or less.  
To try immunopurification with protein-L beads the IgM was purified by HA 
column chromaptgraphy. The eluted fractions from the CHA column when tested 
on gel showed the expected bands for the light and heavy chains. These fractions 
also gave a strong signal at Mr ~85 kDa in the Western blots. The molecular weight 
of this band can be explained by the presence of a covalently linked heterodimer of 
a heavy and a light chain. An additional band at around 45 kDa was also observed. 
A possible explanation for the existence of this band could be a non-reduced 
intramolecular disulphide bridge within an antibody peptide chain or partial 
proteolytic degradation of the antibody. 
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Finally the purified IgM when used to immunoenrich the target antigen by covalent 
coupling to protein-L beads, but was not able to pull down the antigen. Infact 
elution of the Ab chains in the IP sample also indicated non-binding of the mAb to 
the beads.  This could be possible if the IgM did not have the κ-I type of light 
chain. Hence mAb based immunopurification of the antigen seemed to be a 
difficult approach due to the IgM nature of the mAb and the membrane associated 
nature of the target antigen. 
This also explained the failure in initial attempts to purify the antigen by 
immunoprecipitation, as lack of sufficient detergents in the buffers would not 
allow solubilization of the membranes to release the protein into solution for the 
possibility of interaction with the mAb. Integral membrane proteins are also highly 
hydrophobic hence highly prone to aggregation and precipitation at pH values near 
their pI. This could probably explain the lack of success in trying to resolve the 
protein by conventional 2DE (IEF-PAGE). 
Failure of IPs, 2DE and Tricine SDS-PAGE to enrich the protein dentification, 
along with the membrane associated nature, small size of the protein and IgM 
nature of the mAb clearly indicated biochemical purification to be one of only 
possible methods for purification of the antigen sufficient enough to give a single 
specific band in 1DE which would have a corresponding Western signal with the 
mAb so that the protein could be identified by MS analysis. 
Elution of the protein through an anionic exchange column (MonoQ™, GE) as 
peak over two fractions, indicated that the protein is probably anionic in nature. 
These preliminary experiments on biochemical purification gave promising results 
and showed that using biochemical methods the na21 antigen could be purified by 
a series of fractionation, ultracentifugation, dialysis and chromatographic steps. 
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However due to lack of time, the project could not be completed within this 
doctoral thesis, but could very well be pursued in the future based on the available 
data. 
 
4.3 Other mAbs: 
Besides the already mentioned mAbs, the Würzburg Hybridoma Library contains 
about 200 mAbs, which selectively stain specific structures in the brain of 
Drosophila melanogaster. Frontal z-projections of confocal stacks of the staining 
patterns of some of these mAbs are described below. 
4.3.1 ab47: The mAb ab47 was found to be an IgM with κ type of light chain. It 
stained the fan-shaped body and few cells in the central brain, few cells in the pars 
intercerebralis  (PI), few cells in the auxillary medulla, with widespread 
arborizations all over the medulla (Fig. 40).   
 
 
 
Fig. 40. Staining pattern of ab47 (provided by B. Mühlbauer) 
 
4.3.2 ab158: The mAb ab158 stained large cells in the pars intercerebralis (PI) 
with some arborizations in the dorsal part of the brain and innervations to the fan- 
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shaped body. Few cells in the auxillary medulla were also stained with 
arborizations in the medulla (Fig. 41). 
 
  
Fig. 41. Staining pattern of ab158 (provided by B. Mühlbauer) 
 
4.3.3 fb20: The mAb fb20 was found to be an IgM with κ type of light chain. It 
stained a pair of dorsal cells on adjacent to the PI with arborizations in the dorsal 
part of the brain and in a layer of the fan-shaped body. A few cells near the 
auxillary medulla were also stained with innervations into the medulla (Fig. 42). 
 
  
Fig. 42. Staining pattern of fb20 (provided by B. Mühlbauer) 
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4.3.4 nb168: The mAb nb168 was found to stain the adult brain in a pattern (Fig. 
43) similar to the mAb nb33. nb33 is another mAb of the Wuerzburg Hybridoma 
Library which was already known to recognize the PDF precursor peptide and 
hence stained PDF positive neurons (Hofbauer, 2009). To test whether nb168 and 
 
 
Fig. 43. Staining pattern of nb168 (done with B. Blanco) 
 
 
 
Fig. 44. Merge of double staining using anti-PDF and nb168 (done with B. Blanco) 
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nb33 stain the same cells double labeling using nb168 and rabbit anti-PDF 
antibody was done, which showed almost complete merge of the two signals, 
shown below in Fig. 44. Thus it was confirmed that nb168 also recognized PDF 
positive neurons and hence could also be used as a marker antibody for these cells, 
just like nb33. 
4.3.5 nb169: The mAb nb169 was found to be an IgG1. It stained a pair of large 
neurons in the central brain, on either side of the esophageal canal, which 
apparently send out a widespread network of arborizations throughout rest of the 
central brain. Besides the two large neurons, there are also 3-4 smaller neurons 
near the auxillary medulla in the region between the optic neuropils and the central 
brain. In some preparations a thin neurite is seen to connect the few cells near the 
auxillary medulla, passing through the medulla all the way to its outer edge as 
marked by the white arrows in Fig. 45. When observed under higher magnification, 
as shown below in Fig. 46, it is suggested that the stained structure is actually a 
single large neuron with a single nucleus, and not a collection of more than one 
neurons close to one another. The smaller neurons near the auxillary medulla are 
also clearly visible. 
  
Fig. 45. Staining pattern of nb169 (provided by B. Mühlbauer) 
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Fig. 46. 63x magnified confocal image showing large neuron (yellow arrow head) and smaller 
neurons (white arrows) stained by nb169. (Whole brain schematic adapted from JFly 
http://jfly.iam.u-tokyo.ac.jp/html/figures/Head&Brain_Outline/Head&Brain_Outline.html). 
 
 
Analysis of the 3D structure (using Fiji) created by the stack of confocal images 
revealed that the pair of large neurons in the central brain are located in the 
posterior cellular cortex of the brain while their arborizations are directed to the 
anterior side as shown in Fig. 47. Interestingly the nb169 was found to also stain a 
pair of cells on the exterior edges of 5 consecutive segments in larval ventral 
ganglion as shown below in Fig 48. 
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   Fig. 47. Two views of 3D reconstruction of the staining pattern of nb169. 
 
   
Fig. 48. Pairs of cells in 5 consecutive segments in larval whole brain stained by nb169. 
 
4.3.6 nc7: The mAb nc7 was found to specifically stain the trachea and thus 
beautifully revealed the majority of the tracheal network within the adult brain as 
shown below in Fig. 49. 
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Fig. 49. Staining pattern of nc7 (provided by B. Mühlbauer) 
4.4 Discussion 
Besides these mAbs, there are some which stain structures (like eyes, occelli, 
lamina, etc) which are usually removed in whole mount and hence can not be 
stained in such preparations. They are being pursued by immunohistochemistry on 
cryosections. Upon looking at the 5 pairs of cells labeled in larval brains ventral 
ganglion with the mAb nb169 (Fig. 48) and the large pair of cells in the adult with 
the 3-4 pair of smaller cells in the adult brain (Fig. 46) a question that comes to my 
mind is that, could these be the same cells, such that these pairs of cells in the 
larval stage migrates to the central brain during metamorphosis and one of them 
gives rise to the large pair of neuron while the rest migrate near the auxillary 
medulla to become the 3-4 smaller pairs of cells. This can be confirmed by staining 
the adult thoracic ganglion (which develops from the larval ventral ganglion) to see 
if any cells there are stained, similar to the ones stained in the larval ventral 
ganglion. Staining of the pupal CNS could also give more insights into this aspect. 
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The Würzburg Hybridoma Library contains about 200 mAbs, which selectively 
stain specific structures in the brain of Drosophila melanogaster. Unfortunately 
most of these mAbs are still uncharacterized. In many cases these mAbs stain very 
few cells or limited structures, as seen in examples above, thus indicating a very 
low abundance of the endogenously expressed target antigen in the brain. Thus no 
signal in Western blots of homogenized heads are obtained, making it difficult to 
follow the target protein through a purification process. Besides many of the mAbs 
are also IgMs making the enrichment of the target antigen by antibody based 
immopurification strategies difficult. Identification of such mAb antigens would 
unconventional strategies like immunostaining of the specific cells by the mAb 
without fixation in large number of brains, followed by mild proteolytic digestion 
of the tissue, to dissolve the matrix and release cells into a suspension which could 
be then sorted by FACS to enrich for the stained cells, which could then be used 
for IP or other purification methods, to end up with substantial amount of the 
antigen which would probably give a signal in WB and a protein band which could 
be stained by Coomassie, thus ensuring sufficient amount of the protein to be 
identified by peptide mass fingerprinting using mass spectrometry. 
Since immunostaining without fixation and dissolution of brains by mild 
proteolysis are not trivial, there are no established protocols to do this. Due to lack 
of insight and time, such attempts could not be made within the scope of this 
thesis. As a first step to more detailed analysis of such antigens, immunostainings 
were done to characterize the staining patterns, which indicate the localization of 
the target antigens. 
These and other mAbs with specific and interesting staining pattern are currently 
being studied by a colleague Beatriz Blanco and further characterization of such 
mAbs and their target antigens would need more time and work. 
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Chapter 5   SUMMARY 
 
For a large fraction of the proteins expressed in the human brain only the primary 
structure is known from the genome project. Proteins conserved in evolution can 
be studied in genetic models such as Drosophila. In this doctoral thesis monoclonal 
antibodies (mAbs) from the Wuerzburg Hybridoma library are produced and 
characterized with the aim to identify the target antigen. The mAb ab52 was found 
to be an IgM which recognized a cytosolic protein of Mr ~110 kDa on Western 
blots. The antigen was resolved by two-dimensional gel electrophoresis (2DE) as a 
single distinct spot. Mass spectrometric analysis of this spot revealed EPS-15 
(epidermal growth factor receptor pathway substrate clone 15) to be a strong 
candidate. Another mAb from the library, aa2, was already found to recognize 
EPS-15, and comparison of the signal of both mAbs on Western blots of 1D and 
2D electrophoretic separations revealed similar patterns, hence indicating that both 
antigens could represent the same protein. Finally absence of the wild-type signal 
in homozygous Eps15 mutants in a Western blot with ab52 confirmed the ab52 
antigen to be EPS-15. Thus both the mAbs aa2 and ab52 recognize the Drosophila 
homologue of EPS-15. The mAb aa2, being an IgG, is more suitable for 
applications like immunoprecipitation (IP). It has already been submitted to the 
Developmental Studies Hybridoma Bank (DSHB) to be easily available for the 
entire research community.  
The mAb na21 was also found to be an IgM. It recognizes a membrane associated 
antigen of Mr ~10 kDa on Western blots. Due to the membrane associated nature 
of the protein, it was not possible to resolve it by 2DE and due to the IgM nature of 
the mAb it was not possible to enrich the antigen by IP. Preliminary attempts to 
biochemically purify the endogenously expressed protein from the tissue, gave 
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promising results but could not be completed due to lack of time. Thus 
biochemical purification of the protein seems possible in order to facilitate its 
identification by mass spectrometry. Several other mAbs were studied for their 
staining pattern on cryosections and whole mounts of Drosophila brains. However, 
many of these mAbs stained very few structures in the brain, which indicated that 
only a very limited amount of protein would be available as starting material. 
Because these antibodies did not produce signals on Western blots, which made it 
impossible to enrich the antigens by electrophoretic methods, we did not attempt 
their purification. However, the specific localization of these proteins makes them 
highly interesting and calls for their further characterization, as they may play a 
highly specialized role in the development and/or function of the neural circuits 
they are present in. The purification and identification of such low expression 
proteins would need novel methods of enrichment of the stained structures. 
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Chapter 6   ZUSAMMENFASSUNG 
Für einen Großteil der Proteine, die im menschlichen Gehirn exprimiert werden, ist 
lediglich die Primärstruktur aus dem Genomprojekt bekannt. Proteine, die in der 
Evolution konserviert wurden, können in genetischen Modellsystemen wie 
Drosophila untersucht werden. In dieser Doktorarbeit werden monoklonale 
Antikörper (mAk) aus der Würzburger Hybridoma Bibliothek produziert und 
charakterisiert, mit dem Ziel, die erkannten Proteine zu identifizieren. Der mAk 
ab52 wurde als IgM typisiert, das auf Western Blots ein zytosolisches Protein von 
Mr ~110 kDa erkennt. Das Antigen wurde durch zwei-dimensionale 
Gelelektrophorese (2DE) als einzelner Fleck aufgelöst. Massenspektrometrische 
Analyse dieses Flecks identifizierte dass EPS-15 (epidermal growth factor receptor 
pathway substrate clone 15) als viel versprechenden Kandidaten. Da für einen 
anderen mAk aus der Bibliothek, aa2, bereits bekannt war, dass er EPS-15 erkennt, 
wurden die Western-Blot-Signale der beiden Antikörper nach 1D und 2D 
Trennungen von Kopfhomogenat verglichen. Die Ähnlichkeit der beiden Muster 
deuteten darauf hin, dass beide Antigene dasselbe Protein erkennen. Das Fehlen 
des Wildtyp-Signals in homozygoten Eps15 Mutanten in einem Western Blot mit 
mAk ab52 bestätigten schließlich, dass EPS-15 das Antigen zu mAk ab52 darstellt. 
Demnach erkennen beide mAk, aa2 und ab52, das Drosophila Homolog zu EPS-
15. Da mAk aa2 ein IgG ist, dürfte er für Anwendungen wie Immunpräzipitation 
(IP) besser geeignet sein. Er wurde daher bereits bei der Developmental Studies 
Hybridoma Bank (DSHB) eingereicht, um ihn der ganzen Forschergemeinde leicht 
zugänglich zu machen.  
Der mAk na21 wurde ebenfalls als IgM typisiert. Er erkennt ein Membran 
assoziiertes Antigen von Mr ~10 kDa auf Western Blots. Aufgrund der 
Membranassoziierung des Proteins war es nicht möglich, es in 2DE aufzulösen und 
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da es sich um ein IgM handelt, war eine Anreicherung des Antigens mittels IP 
nicht erfolgreich. Vorversuche zur biochemischen Reinigung des endogenen 
Proteins aus Gewebe waren Erfolg versprechend, konnten aber aus Zeitmangel 
nicht abgeschlossen werden. Daher erscheint eine biochemische Reinigung des 
Proteins für eine Identifikation durch Massenspektrometrie möglich. 
Eine Reihe weiterer mAk wurden hinsichtlich ihrer Färbemuster auf 
Gefrierschnitten und in Ganzpräparaten von Drosophila Gehirnen untersucht. 
Allerdings färbten viele dieser mAk sehr wenige Strukturen im Gehirn, so dass nur 
eine sehr begrenzte Menge an Protein als Startmaterial verfügbar wäre. Da diese 
Antikörper keine Signale auf Western Blots produzierten und daher eine 
Anreicherung des Antigens durch elektrophoretische Methoden ausschlossen, 
wurde keine Reinigung versucht. Andererseits macht die spezifische Lokalisation 
dieser Proteine sie hoch interessant für eine weitere Charakterisierung, da sie eine 
besonders spezialisierte Rolle in der Entwicklung oder für die Funktion von 
neuralen Schaltkreisen, in denen sie vorkommen, spielen könnten. Die Reinigung 
und Identifikation solcher Proteine mit niedrigem Expressionsniveau würde neue 
Methoden der Anreicherung der gefärbten Strukturen erfordern. 
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